Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094554	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1"	"Cell line enriched"	"Detected in single"	38	"RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.4	0.3	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	22.4	0.0	0.1	0.6	0.1	0.1	13.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	11.6	1.2	0.6	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UGT2A2		ENSG00000271271	"UDP glucuronosyltransferase family 2 member A2"	Q9Y4X1	4	69589309-69639642	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA045108	Uncertain									"HPA045108: AB_2679218"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.4	0.0	0.0	0.0		0.0	0.0	0.0	3.8	0.0		0.0	0.0		0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL19	"IL-10C, IL-19, MDA1, NG.1, ZMDA1"	ENSG00000142224	"Interleukin 19"	Q9UHD0	1	206798870-206842981	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 11.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"					"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (6.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.17e-2)"		"unprognostic (2.48e-5)"		"unprognostic (1.07e-1)"	"unprognostic (8.72e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.04e-3)"			"unprognostic (9.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0			0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		6.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2			0.3		0.3	0.9	0.8	0.7	0.6	1.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	11.6	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.7	0.1	0.6	0.1	0.3	0.4	0.2	0.1	0.0	0.2	0.6	0.0	0.0										
STRA6	FLJ12541	ENSG00000137868	"Stimulated by retinoic acid 6"	Q9BX79	15	74179466-74212267	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix, uterine: 22.7;placenta: 88.6;retina: 42.8"	"Cell line enhanced"	"Detected in some"		"A549: 16.2;CAPAN-2: 46.0;SH-SY5Y: 28.6;WM-115: 69.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040839	Approved									"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.2	1.6	0.2	0.5	0.3	0.0	1.1	0.2	0.5	22.7	0.1	0.3	1.6	0.0	6.9	2.8	1.0	5.0	0.7	0.3	0.4	0.2	7.3	0.0	0.3	1.1	0.1	0.3	0.6	0.2	0.0	5.3	88.6	0.7	5.0	0.0	42.8	0.6	2.6	0.1	0.4	0.2	0.3	1.5	0.3	0.1	2.8	0.1	0.9	0.2	1.4	1.9	1.8	2.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	16.2	0.9	0.0	0.0	0.0	2.7	0.5	0.1	0.0	0.0	5.6	46.0	0.0	11.1	0.0	1.6	0.9	0.0	0.0	0.0	0.0	1.4	0.6	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.2	1.4	0.0	0.2	0.0	0.0	0.0	1.5	8.7	28.6	0.0	1.6	0.0	0.1	0.0	0.0	0.1	3.8	0.3	0.7	0.0	0.1	0.0	0.3	0.0	69.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.4	0.2	0.1	0.3	0.7	0.1
CHST6	MCDC1	ENSG00000183196	"Carbohydrate sulfotransferase 6"	Q9GZX3	16	75472052-75495384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 7.2;brain: 22.6;cervix, uterine: 18.6;intestine: 16.8;salivary gland: 20.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.1;CAPAN-2: 13.3;NTERA-2: 6.4;SK-MEL-30: 5.3;U-2 OS: 8.1;WM-115: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (2.28e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.80e-4)"	0.8	7.2	10.1	1.1	17.4	0.8	0.7	8.3	11.6	18.6	5.9	22.6	0.0	16.8	1.4	1.1	2.5	2.9	0.8	2.3	9.4	5.5	1.1	0.6	1.4	0.8	17.6	4.9	0.7	0.7	1.1	1.4	0.8	18.5	1.3	5.9	0.4	20.1	1.0	0.9	0.9	15.5	1.3	19.5	0.9	1.3	1.3	13.6	0.0	0.8	0.0	0.8	0.9	0.5	1.2	0.8	2.5	0.5	1.4	0.7	0.2	0.2	0.6	0.8	12.1	0.2	0.5	0.2	0.1	0.0	0.0	0.1	0.2	13.3	0.1	1.8	0.1	0.1	1.1	0.2	0.1	0.0	0.3	0.0	0.2	1.2	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	6.4	0.2	0.0	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.1	5.3	0.1	0.4	0.2	0.1	8.1	0.1	0.0	0.3	0.2	3.1	0.4	0.0	7.0	2.5	0.5	0.4	0.6	0.3	0.5	0.8	0.4	0.4	0.1	1.2	0.5	0.7	2.0	1.4	0.3	0.8	0.3	0.2	10.1	17.4	8.3	11.6	9.4	5.5	17.6	4.9	18.5	13.6
FGF14	"FHF4, SCA27"	ENSG00000102466	"Fibroblast growth factor 14"	Q92915	13	101710804-102402457	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 46.4;cervix, uterine: 23.2;fallopian tube: 15.7"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Region enhanced"	"Detected in all"		"cerebellum: 46.4"	"Group enriched"	"Detected in some"	11	"memory CD4 T-cell: 1.0;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049828			Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA049828: AB_2680901"	"unprognostic (2.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.80e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.48e-2)"	1.6	4.4	6.0	0.8	12.1	0.4	0.8	46.4	13.6	23.2	0.9	1.0	0.1	1.2	0.8	1.5	2.4	15.7	1.1	3.5	4.5	10.4	1.3	2.1	3.0	0.6	2.3	4.5	0.5	1.5	0.5	4.6	0.6	6.5	0.7	1.1	0.0	1.2	1.4	0.7	1.2	0.8	0.8	1.8	0.6	3.2	3.5	3.6	0.0	0.7	0.0	0.5	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	4.8	20.5	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.3	0.3	0.0	0.3	0.0	0.0	4.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	6.0	12.1	46.4	11.4	4.5	10.4	2.3	4.5	6.5	3.6
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1"	"Group enriched"	"Detected in some"	132	"HaCaT: 64.1;hTCEpi: 24.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		59000	59000	"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.1	37.7	0.1	0.0	0.0	0.1	3.1	0.1	70.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	10.9	0.1	0.2	5.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.0	0.1	107.2	54.2	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 155.4;hTCEpi: 182.5;SiHa: 54.7;THP-1: 46.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	2600000	2600000	"Golgi apparatus"	"Golgi apparatus"	"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	155.4	0.0	11.6	0.0	5.6	0.0	0.7	0.0	0.0	20.8	0.0	30.0	0.0	0.0	0.8	182.5	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.6	0.0	0.0	0.0	31.6	1.2	0.0	0.0	54.7	11.7	0.1	0.2	46.2	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0
TBC1D3H		ENSG00000274226	"TBC1 domain family member 3H"	P0C7X1	17	36377531-36388423	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3"	"Cell line enriched"	"Detected in some"	10	"CAPAN-2: 11.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.2	0.0		0.0	1.6	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.0			0.0		0.0	3.3		0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1										
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112559	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5"	"Group enriched"	"Detected in some"	11	"RH-30: 8.1;U-2 OS: 3.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted - unknown location"					"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.3	10.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	7.3	0.0	11.5	3.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	5	"cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;Daudi: 3.0;RH-30: 10.9;RPMI-8226: 3.8;U-266/70: 3.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"				"Plasma membrane"	"Plasma membrane"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.28e-5)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (2.08e-1)"	1.7	0.6	1.7	5.9	1.8	0.0	2.7	0.2	1.6	13.9	43.3	0.8	0.7	15.2	0.2	0.4	0.2	0.0	46.6	0.7	0.6		0.6	0.2	0.6	0.2	0.9	0.6	0.6	0.2	0.0	1.2	1.5	1.1	0.4	16.7	0.3	1.3	1.2	0.2	2.8	16.9	0.2	2.1	0.2	17.0	0.4	0.9	0.5	20.9	0.2	0.5	0.2	0.2	0.6	2.3	0.0	0.9	1.3	3.2	0.6	0.0	9.7	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.3	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	2.8	1.2	0.3	0.7	0.2	10.9	3.8	0.2	1.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	0.3	0.0	0.7	1.4	2.3	0.6	0.9	3.2	0.0	1.3	0.5	0.0	0.2	0.6										
GABRQ	THETA	ENSG00000268089	"Gamma-aminobutyric acid type A receptor theta subunit"	Q9UN88	X	152638183-152657534	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 28.9;cervix, uterine: 16.2"	"Group enriched"	"Detected in some"	7	"HeLa: 8.8;SiHa: 8.6;U-87 MG: 28.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"hypothalamus: 61.6"	"Region enhanced"	"Detected in many"		"midbrain: 24.9"												"unprognostic (3.68e-3)"	"unprognostic (7.78e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.10e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.70e-2)"	0.2	4.4	10.5	0.2	5.7	0.1	0.1	0.0	7.5	16.2	0.2	1.5	1.0	0.2	2.6	0.5	1.1	0.3	0.1	0.2	23.4		0.2	0.1	0.1	0.2	0.0	13.6	0.1	0.1	0.1	0.0	0.3	28.9	0.9	0.2	0.0	0.1	1.7	0.1	0.7	0.5	1.6	7.2	0.2	0.1	4.7	1.0	0.0	0.3	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	2.2	0.0	0.0	0.0	0.0	1.2	8.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 43.5;hTCEpi: 32.4;RT4: 50.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.3	43.5	0.0	0.2	0.0	8.6	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.4	0.5	6.0	0.0	0.0	3.2	0.0	0.4	0.3	0.0	0.1	4.3	0.0	0.0	2.4	0.0	50.5	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.2	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101130524	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 50.7;endometrium 1: 116.4;smooth muscle: 31.2"	"Cell line enriched"	"Detected in single"	349	"T-47d: 60.8"	"Group enriched"	"Detected in some"	13	"breast cancer: 10.1;endometrial cancer: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced									"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"	"unprognostic (2.59e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.23e-3)"	"prognostic favourable (5.76e-8)"	"unprognostic (2.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.44e-3)"	0.8	0.7	0.2	0.3	0.6	0.0	5.0	0.2	0.7	50.7	1.3	0.2	0.4	0.0	116.4	6.1	0.5	13.2	0.4	2.0	0.5	0.6	0.4	0.1	1.2	0.3	0.4	0.1	10.6	0.8	0.0	2.8	1.8	0.8	3.8	0.1	0.7	3.5	5.5	0.3	0.3	1.2	31.2	0.9	0.5	0.4	1.5	0.3	0.1	0.3	0.8	0.2	1.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.7	0.5	0.6	0.4	0.1	0.8	0.3
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590103-180591540	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 6.2;T-47d: 2.3;U-2197: 2.1"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 25.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	8000000	8000000				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	0.2	0.1	0.1	0.1	0.3	0.1	23.5	0.1	0.2	56.1	0.1	0.1	0.1	0.1	2.3	1.6	12.1	5.7	113.1	0.3	0.1	0.6	0.1	0.5	176.2	0.1	0.1	0.1	1.5	2.9	0.0	1.6	0.1	0.2	4.5	0.0	0.3	196.6	0.6	0.2	0.4	0.1	0.1	0.1	1.6	9.6	0.3	0.1	0.2	0.2	8.4	19.9	3.9	0.1	0.7	5.3	10.3	25.1	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.4	2.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.3	1.5	8.2	7.2	0.7	1.9	2.5	5.3	0.0	3.3	2.6	0.0	0.0	25.1	0.1	2.2	1.2	0.1	0.3	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1
SLC5A8	AIT	ENSG00000256870	"Solute carrier family 5 member 8"	Q8N695	12	101155493-101210407	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2"	"Cell line enriched"	"Detected in single"	10	"SK-BR-3: 8.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (9.04e-6)"	"unprognostic (1.84e-1)"		"unprognostic (1.17e-2)"		"unprognostic (1.27e-3)"		"unprognostic (1.24e-1)"			"unprognostic (5.20e-1)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (6.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.87e-2)"		0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	14.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.8	0.0	1.9	0.0	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.6	0.9	0.0	1.4	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	21.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.6	0.0
ASIC2	"ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG"	ENSG00000108684	"Acid sensing ion channel subunit 2"	Q16515	17	33013087-34174964	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;cervix, uterine: 6.8;endometrium 1: 9.5;smooth muscle: 3.9"	"Group enriched"	"Detected in some"	4	"NTERA-2: 4.2;PC-3: 1.1;RPTEC TERT1: 3.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052112	Enhanced									"HPA052112: AB_2681733"	"unprognostic (3.40e-1)"	"unprognostic (2.45e-2)"	"unprognostic (8.50e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	0.4	1.9	8.1	0.4	6.3	0.3	0.7	8.7	13.1	6.8	0.7	1.1	0.0	1.2	9.5	0.5	0.4	1.5	0.5	0.4	7.7	10.0	1.2	0.4	0.5	0.4	4.6	5.5	0.4	0.4	0.3	0.5	0.5	3.7	0.6	0.8	0.2	0.3	1.7	0.3	0.6	1.2	3.9	2.3	0.4	0.5	1.1	0.8	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	1.1	0.0	0.0	0.5	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.3	8.7	9.6	7.7	10.0	4.6	5.5	3.7	0.8
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025669	Supported				"Secreted in other tissues"	1200000	1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 459.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		7200000000	7200000000	"Intermediate filaments"	"Intermediate filaments"	"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavourable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.7	0.0	111.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CAPAN-2: 5.5;HaCaT: 5.3;HeLa: 26.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"					"CAB055172: AB_2148831, HPA065600: AB_2732736"	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.3	0.0			0.0	2.4	0.0	0.2	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.0		6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.4	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296277-62299064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8"	"Group enriched"	"Detected in some"	20	"HL-60: 3.1;Karpas-707: 1.0;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	27.5	0.1	0.1	9.9	0.0	9.5	27.9	0.1	36.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208668-62213939	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 191.8;epididymis: 135.9"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 13.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 971.9;ovarian cancer: 208.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favourable (1.22e-4)"	"prognostic favourable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favourable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.2	0.0	0.2	0.5	0.2	0.0	6.8	0.2	0.3	191.8	1.0	0.3	20.8	0.0	40.8	135.9	1.0	28.7	2.5	0.4	0.2	0.3	1.2	0.4	0.9	0.2	0.2	0.3	5.6	2.2	0.0	1.5	0.7	0.5	1.2	1.3	0.2	18.8	1.4	0.2	2.3	0.3	0.2	0.2	0.2	4.3	4.5	0.2	0.3	0.8	1.1	3.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	2.5	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.2
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HaCaT: 8.9;SiHa: 5.5;U-2197: 11.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		11000000	11000000	Cytosol	Cytosol	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: , HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavourable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.1	8.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644298	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 32.5;esophagus: 48.4;tongue: 18.4;vagina: 41.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;HSkMC: 2.0;SiHa: 3.1;U-2197: 10.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048341, HPA049988, HPA055992"	Supported					5700000	5700000			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	32.5	0.1	0.1	0.1	0.0	1.8	0.1	48.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	7.0	0.1	0.3	4.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.1	18.4	2.3	8.7	41.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TMEM211	bA9F11.1	ENSG00000206069	"Transmembrane protein 211"	Q6ICI0	22	24934954-24946695	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 5.3;salivary gland: 6.6;stomach 1: 5.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HEK 293: 1.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.8;endometrial cancer: 3.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066784	Uncertain									"HPA066784: AB_2685722"	"unprognostic (7.89e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.09e-2)"		"unprognostic (5.97e-3)"		"unprognostic (5.88e-2)"		"unprognostic (1.31e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.0	0.4	0.4	0.0	0.8	0.4	0.1	5.3	0.4			0.0	1.2	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.2	0.0	0.2	0.0		0.1	0.1		6.6	0.0	0.0	1.4	0.1	0.0	0.0	0.0	5.8	0.1			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TMPRSS11D		ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884032	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052834	Uncertain				"Intracellular and membrane"					"HPA052834: AB_2681969"	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	67.6	20.3	0.4	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469706-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7"	"Group enriched"	"Detected in some"	9	"A-431: 26.2;CAPAN-2: 49.1;EFO-21: 41.0;HaCaT: 35.8;RPTEC TERT1: 38.1"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 1815.6"	"Region enriched"	"Detected in single"	5	"basal ganglia: 3.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"					"Group enriched"	"Detected in many"	13	"basal ganglia: 10.7;hypothalamus: 32.7;midbrain: 14.3;pons and medulla: 12.8;thalamus: 8.5"	HPA042302	Enhanced				"Secreted in other tissues"	1300000	1300000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	1.2	0.1	0.3	1.5	3.0	0.0	10.6	0.2	0.6	352.3	11.0	0.4	143.4	0.7	19.4	385.4	4.5	44.6	10.4	0.4	0.3	0.3	135.1	9.9	31.6	0.2	0.3	0.3	20.4	5.0	5.0	14.9	1.3	0.5	27.2	14.7	2.2	343.7	60.9	0.2	2.8	5.0	10.9	0.2	0.1	3.8	15.6	0.5	0.7	45.5	15.3	29.1	21.9	6.9	0.0	1.2	0.0	0.0	0.0	0.0	0.1	26.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	49.1	0.0	41.0	0.0	35.8	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.6	4.3	0.0	0.0	0.0	0.0	38.1	0.3	1.2	0.2	2.4	0.0	0.2	0.7	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	3.0	0.2	0.6	0.3	0.3	0.3	0.3	0.5	0.5
AC004080.3		ENSG00000257184			7	27163535-27180013	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 24.9;endometrium 1: 20.7;prostate: 12.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.8;BJ: 4.3;BJ hTERT+ SV40 Large T+: 1.5;HEK 293: 2.9;RPTEC TERT1: 2.2;U-937: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (4.27e-1)"									"unprognostic (4.63e-1)"		"unprognostic (4.49e-1)"				1.6	0.2	0.3	1.8	0.3	0.0	0.2	0.3	0.3	24.9	6.9	0.0	1.0	0.0	20.7	2.1	0.2	0.2	0.0	0.3	0.2	0.3	4.7	0.3	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.3	4.6	0.0	12.9	1.1	0.0	0.2	1.2	6.9	0.3	0.5	6.7	0.2	0.2	0.2	1.0	0.0	0.0	0.3	0.0	0.0	7.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.2	4.3	0.8	1.5	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.0	0.0	0.0
AC019117.3		ENSG00000283321			7	17299295-17467234	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 9.9;urinary bladder: 21.3"	"Cell line enriched"	"Detected in some"	5	"RT4: 34.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029722	Uncertain									"HPA029722: AB_10599189"																		2.8	0.1	0.0	1.5	0.0	0.6	1.3	0.0	2.2	9.9	0.9	0.0	0.5	0.3	1.7	0.8	1.3	2.2	1.6	0.7	0.0		1.0	1.8	2.5	4.8	0.0	0.0	1.1	4.1	0.0	0.0	3.3	0.4	1.6	0.3	0.7	0.8	3.9	0.0	0.5	0.1	4.8	1.3	1.8	1.1	0.4	0.3	0.3	0.6	2.4	1.3	21.3	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC136616.3		ENSG00000278782			Unmapped	1157687-1240349	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 6.6;breast: 4.8;cervix, uterine: 6.8;intestine: 5.2;lymphoid tissue: 7.7"	"Cell line enriched"	"Detected in single"	16	"U-251 MG: 1.6"									"Cell type enriched"	"Detected in some"	6	"naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 6.6"																																					0.0	0.0		0.1		0.4	4.8		0.0	6.8	2.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.5		1.6	0.0	0.0	0.0	5.2	0.0		2.0	0.0	0.0			0.0		7.7	3.6		6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
ACTBL2	DKFZp686D0972	ENSG00000169067	"Actin, beta like 2"	Q562R1	5	57480016-57482809	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 2.4;placenta: 4.2;skin 1: 3.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HaCaT: 1.7;RPTEC TERT1: 3.9;SiHa: 6.8;U-2 OS: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041264, HPA041271"	Uncertain					2600000000	2600000000			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.83e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.66e-2)"		"unprognostic (2.57e-2)"		"unprognostic (2.39e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.60e-2)"		"unprognostic (2.04e-2)"	"unprognostic (1.92e-2)"	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.8	0.0	0.0	1.2	0.1	0.1	3.4	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.3	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM33	"C20orf153, dJ964F7.1, DKFZp434K0521"	ENSG00000149451	"ADAM metallopeptidase domain 33"	Q9BZ11	20	3667965-3682246	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 55.7;smooth muscle: 58.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 30.7;ASC TERT1: 39.7;BJ: 13.5;BJ hTERT+: 23.2;fHDF/TERT166: 13.8;U-2197: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in all"			"HPA067152, HPA071758"	Approved		Uncertain	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA067152: AB_2685791, HPA071758: "	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.43e-4)"	"unprognostic (7.14e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.75e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-5)"	"unprognostic (3.10e-3)"	10.0	1.5	4.6	9.2	2.6	0.0	20.2	2.8	2.7	55.7	29.5	2.2	20.9	4.7	44.3	12.3	17.0	16.9	17.5	5.3	5.0	0.9	0.9	0.5	3.6	2.2	4.9	3.0	11.8	1.6	0.0	1.6	5.4	7.0	22.8	5.5	3.7	4.2	27.1	3.5	4.8	9.1	58.0	3.3	1.9	9.9	5.4	3.5	0.1	4.0	10.1	2.0	24.9	36.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	39.7	0.1	13.5	23.2	4.0	7.9	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	6.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.6	2.6	2.8	2.7	5.0	0.9	4.9	3.0	7.0	3.5
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	8	"MCF7: 11.7;SH-SY5Y: 27.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"			"Vesicles, Midbody"	"Vesicles, Midbody"	"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8
ADAMTSL5	THSD6	ENSG00000185761	"ADAMTS like 5"		19	1505018-1513604	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 19.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044050			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"			"Golgi apparatus"	"Golgi apparatus"	"HPA044050: AB_10962625"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.37e-3)"	1.0	1.0	1.2	1.7	1.5	0.0	1.5	1.3	1.2	19.3	5.0	0.5	2.2	7.8	14.4	6.2	7.0	2.7	2.3	13.5	1.9	0.8	0.9	2.8	1.4	0.2	0.9	0.2	1.7	0.9	0.0	1.5	5.2	1.8	4.0	0.7	8.6	4.0	3.9	10.5	1.0	10.0	9.9	0.8	0.8	1.0	3.7	0.3	0.0	1.0	8.1	5.1	1.6	7.2	0.2	0.1	0.8	1.8	0.1	4.7	1.1	6.3	2.8	0.1	0.2	3.4	2.5	3.1	11.7	7.9	4.6	6.7	16.1	3.1	0.0	3.0	9.7	5.4	2.8	3.4	3.4	6.1	0.4	1.2	8.3	3.0	3.8	0.2	8.3	1.5	3.7	1.1	2.9	0.0	3.8	8.1	0.4	5.8	0.3	0.4	0.1	1.6	0.2	0.6	1.6	3.6	0.0	0.2	0.4	2.8	0.3	3.3	7.3	2.4	0.7	0.0	4.4	8.9	0.5	5.0	3.1	0.8	0.1	0.6	2.0	0.4	0.1	0.8	3.4	1.1	2.2	0.1	3.7	2.5	0.1	0.2	4.7	3.2	0.2	0.1	1.8	0.1	1.1	1.1	1.2	1.5	1.3	1.2	1.9	0.8	0.9	0.2	1.8	0.3
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.0;MCF7: 18.2;NTERA-2: 6.4;SCLC-21H: 7.0;SH-SY5Y: 8.5;T-47d: 6.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 41.4"	HPA057688	Uncertain									"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	6.5	2.4	2.1	1.0	9.8	0.4	9.2	0.5	2.6	35.1	1.5	0.6	12.8	1.0	20.3	18.0	2.1	6.4	5.5	3.0	1.2	1.0	9.2	1.3	2.0	1.2	0.7	1.6	7.6	4.1	0.5	4.2	27.6	1.1	7.3	0.6	3.6	0.8	24.6	2.6	2.1	0.9	3.0	0.7	7.5	0.7	6.2	2.0	0.2	0.8	1.9	0.5	2.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.1	0.5	0.0	0.2	0.4	0.0	0.0	0.0	2.0	1.2	0.0	2.1	0.3	0.0	0.2	0.0	0.0	0.0	5.6	0.0	0.0	11.0	0.6	0.0	0.8	0.9	0.4	0.0	0.0	0.0	0.4	0.0	2.7	18.2	0.0	0.0	6.4	0.0	0.0	5.9	0.0	0.0	0.3	7.0	8.5	2.5	0.0	0.1	6.0	0.1	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	9.8	0.5	1.4	1.2	1.0	0.7	1.6	1.1	2.0
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	5	"A-431: 17.1;HEL: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Cytosol"		5800000	5800000	Cytosol	Cytosol	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.1	2.9	1.3	1.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	2.5	0.6	0.8	0.6	0.0	2.2	0.0	0.1	0.0	1.8	2.2	27.4	3.8	1.8	0.1	0.2	4.5	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.2	0.3	0.6	0.9	0.6	0.9	0.5	0.4	0.0	2.2	0.1	0.6	0.5	0.5	0.2	1.0	0.7	3.2	1.5	0.8	1.4	0.7	0.5	0.2	0.5	0.8	2.0	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3
ANGPT4		ENSG00000101280	"Angiopoietin 4"	Q9Y264	20	869899-916317	"Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8"	"Group enriched"	"Detected in some"	80	"ASC diff: 21.1;BEWO: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013260, CAB013305"	Uncertain				"Secreted to blood"					"CAB013260: , CAB013305: "	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.82e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.66e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.95e-4)"	"unprognostic (9.14e-2)"	18.7	0.7	0.1	0.1	0.3	0.1	12.3	0.0	0.5	16.8	1.4	0.6	2.1	0.2	7.1	4.9	1.2	3.5	2.5	1.1	0.1	0.3	0.4	0.1	2.6	0.1	0.3	0.0	4.8	0.2	0.1	0.0	0.4	0.3	1.8	0.1	2.4	1.3	2.2	0.2	1.4	0.3	2.6	0.1	0.1	0.4	3.7	0.0	0.0	2.1	1.6	0.4	1.3	2.2	0.3	0.6	2.4	0.9	0.2	0.3	0.5	0.1	0.0	0.0	0.0	21.1	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.9	0.4	0.2	0.5	0.0	0.1	0.2	0.3	0.6	0.3	0.1	0.2	0.8	0.2	0.6	0.2	0.0	0.5	0.1	0.3	0.0	0.5	0.1	0.3	0.3	0.0	0.3	0.0
ANKFN1	FLJ38335	ENSG00000153930	"Ankyrin repeat and fibronectin type III domain containing 1"	Q8N957	17	55882301-56511659	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 7.9;MOLT-4: 16.4;T-47d: 5.7;U-2197: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA021566, HPA022538, HPA048953"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: "	"unprognostic (6.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.38e-5)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.44e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.93e-2)"	"unprognostic (9.51e-2)"	3.9	1.0	5.5	0.5	10.2	0.5	1.2	2.6	4.7	19.9	0.7	11.4	0.5	0.7	0.8	3.4	0.7	10.9	0.9	0.5	6.8	4.6	0.7	0.6	2.0	0.6	6.3	3.7	0.5	0.5	0.5	1.0	2.1	11.8	0.9	0.8	0.0	0.7	0.8	0.6	5.2	0.8	0.5	7.5	0.6	1.1	3.6	10.0	0.0	0.6	0.0	0.5	3.2	5.3	0.2	0.5	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.3	0.2	0.3	0.0	2.8	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.1	0.1	0.4	16.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	1.5	0.0	1.7	0.0	0.3	5.7	0.0	0.0	0.0	0.4	5.5	0.1	1.5	0.3	0.0	0.8	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.3	0.1	0.5	0.0	0.0	5.5	10.2	2.6	4.7	6.8	4.6	6.3	3.7	11.8	10.0
AP000812.4		ENSG00000284844			11	72105924-72109329	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 1.1;cervix, uterine: 1.1;testis: 2.0"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.4;RH-30: 1.2;SK-MEL-30: 2.9;WM-115: 1.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		1.1	0.0		0.9	1.1	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.6	0.0	0.0	0.0		0.0	0.0	2.0			0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.5	0.4	0.0	0.0	0.0	0.9	0.5	0.2	0.1	0.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase like 1"	Q7L266	11	62337448-62393412	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.4;cervix, uterine: 68.7;testis: 57.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.0;HAP1: 28.9;RPTEC TERT1: 25.6;SCLC-21H: 39.5"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 51.4;eosinophil: 52.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 52.4;monocytes: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	Nucleoplasm,Microtubules				Microtubules	Microtubules	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favourable (6.14e-4)"	"prognostic favourable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favourable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	3.6	2.6	27.8	3.8	37.0	7.1	4.6	12.3	22.3	68.7	7.9	9.9	2.0	4.1	15.3	7.9	1.4	36.8	9.5	1.7	19.5	19.0	23.8	2.4	6.6	3.3	30.8	11.8	1.6	5.1	1.5	5.7	2.3	16.4	8.6	9.9	4.9	6.4	4.8	2.3	1.2	3.1	3.0	9.6	2.4	5.6	57.6	11.3	2.8	3.7	0.0	3.0	2.9	1.0	0.5	8.2	52.4	14.2	2.5	0.7	4.9	0.8	6.6	7.3	9.4	0.0	0.0	5.8	0.8	0.2	1.3	1.2	10.8	2.9	0.6	30.0	0.1	0.6	28.9	0.3	1.5	1.1	11.9	0.4	9.0	7.8	0.2	8.0	10.8	0.3	0.1	0.6	0.1	13.6	8.0	7.5	0.3	12.6	21.5	5.3	9.9	5.2	8.7	4.4	4.0	25.6	2.0	39.5	5.6	5.6	9.8	4.8	5.2	4.1	0.7	0.1	5.5	0.4	3.2	11.5	10.9	1.0	0.3	4.1	3.3	51.4	14.2	52.4	0.6	10.3	0.4	0.5	0.2	0.7	8.2	0.4	0.5	0.7	3.3	2.5	7.2	1.4	0.1	4.9	27.8	37.0	12.3	22.3	19.5	19.0	30.8	11.8	16.4	11.3
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 6.9;NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040254	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	2.3	1.2	1.6	1.5	2.1	28.1	1.0	0.6	0.9	26.0	1.5	1.7	1.6	0.4	18.2	3.5	0.6	9.5	3.1	0.8	2.5	0.9	1.0	1.2	3.2	0.7	2.7	0.1	3.9	0.4	0.2	1.1	2.9	2.1	0.7	1.2	0.8	0.9	0.6	0.4	0.5	1.1	2.7	3.1	2.3	0.6	0.9	4.6	0.8	0.5	0.8	2.1	1.3	1.5	0.0	2.2	6.9	1.7	10.6	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	3.0	0.6	0.0	0.0	5.2	18.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	12.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	37.6	0.0	6.9	1.7	2.4	0.5	0.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	10.6	0.3	0.0	0.0	0.8	1.6	2.1	0.6	0.9	2.5	0.9	2.7	0.1	2.1	4.6
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Cell line enhanced"	"Detected in many"		"A549: 18.3;MCF7: 9.2;SH-SY5Y: 15.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favourable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.3	4.9	0.0	1.9	4.5	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	1.0	2.9	6.7	0.0	0.0	4.5	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.5	2.8	5.6	0.0	0.0	0.0	7.0	9.2	0.6	0.1	1.8	3.1	0.1	2.7	0.1	3.5	0.1	0.2	15.3	0.2	2.5	2.5	1.9	0.0	0.0	3.9	3.1	0.1	3.3	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309878	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HMC-1: 2.0;RT4: 4.1;SK-BR-3: 8.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 6.2"	"Low region specificity"	"Detected in all"			HPA024256	Enhanced				"Secreted in other tissues"	7500000	7500000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	100.1	0.1	0.3	0.1	3.7	0.5	0.2	23.3	0.0	0.3	0.3	0.2	0.0	0.1	0.1	101.0	0.1	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.9	0.0	0.1	38.8	0.8	1.0	0.0	0.1	0.1	0.1	0.1	76.9	1.1	0.1	0.2	0.2	29.6	115.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.7	0.0	0.3	0.0	4.1	0.0	0.0	0.0	8.4	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.0;ASC TERT1: 6.2;HSkMC: 3.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"CAB007055: , HPA051797: AB_2681614, HPA055392: "	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 59.5;cervix, uterine: 23.4"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.1;RT4: 3.7;SCLC-21H: 11.4"	"Cancer enhanced"	"Detected in some"		"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"			Vesicles	Vesicles	"HPA054825: AB_2682617, HPA057837: AB_2683542"		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.5	3.8	14.4	0.5	6.3	0.5	0.5	59.5	36.7	23.4	0.8	1.7	0.0	0.8	0.7	0.5	0.6	0.7	0.6	0.5	8.0	12.4	7.8	0.5	0.5	0.5	7.0	5.0	2.5	0.8	0.5	1.8	14.2	18.3	0.5	0.7	2.9	1.5	0.5	0.5	0.5	1.1	0.6	4.2	0.5	0.6	6.0	1.3	0.0	0.5	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.1	3.7	11.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	6.3	59.5	17.9	8.0	12.4	7.0	5.0	18.3	1.3
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50561068-50627474	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.8;cervix, uterine: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;HeLa: 4.6;SCLC-21H: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain									"HPA004714: AB_1078368"	"unprognostic (1.90e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.87e-12)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.63e-2)"	1.7	1.0	3.5	0.9	5.2	1.3	2.1	22.8	17.1	13.6	1.0	2.7	0.0	0.9	7.4	1.0	1.6	5.7	1.2	3.8	2.4	8.8	0.7	1.1	0.9	1.2	5.3	7.9	7.1	0.6	0.6	0.4	1.4	6.1	2.5	0.8	4.3	1.1	1.6	0.8	3.9	0.8	2.1	5.9	0.9	0.9	1.7	2.3	0.0	1.2	0.0	1.0	1.0	3.9	1.3	1.3	2.7	0.8	0.7	1.4	0.0	0.0	13.3	3.1	3.5	0.9	0.1	0.2	0.1	0.0	0.1	0.1	2.8	0.5	0.0	1.0	0.1	0.5	1.6	0.0	0.3	1.8	0.6	0.9	4.6	0.7	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	1.2	0.8	1.4	1.1	0.0	0.0	0.2	4.1	1.8	2.8	0.1	0.0	0.2	0.1	0.3	1.4	3.9	0.5	0.1	1.0	0.1	0.0	0.5	0.1	0.5	0.5	0.8	0.6	1.4	0.4	0.7	0.8	0.7	0.8	0.2	1.3	0.9	1.0	2.7	0.7	0.4	1.3	0.5	0.0	3.5	5.2	22.8	17.1	2.4	8.8	5.3	7.9	6.1	2.3
CCDC80	"DRO1, SSG1, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596794-112649530	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 130.0;endometrium 1: 143.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 64.4;ASC TERT1: 51.2;BJ: 42.5;fHDF/TERT166: 150.4;HSkMC: 50.5;LHCN-M2: 42.1;U-138 MG: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002266	Approved				"Secreted to extracellular matrix"	57000	57000			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (1.26e-4)"	49.5	3.3	1.4	16.4	3.1	0.0	39.4	3.1	3.3	130.0	14.9	3.4	54.7	1.1	143.8	94.7	34.2	17.4	39.7	87.6	2.3	2.8	10.7	2.1	17.0	10.1	3.0	1.0	53.3	6.6	2.5	2.7	6.0	7.2	28.6	12.7	8.7	8.7	21.7	4.1	19.2	8.6	81.3	14.0	19.8	12.0	14.0	3.3	4.1	20.4	29.6	10.8	57.3	33.8	2.9	3.0	2.9	1.3	1.3	2.1	0.2	3.0	1.3	15.4	0.7	64.4	51.2	0.8	42.5	12.9	14.3	21.0	0.3	0.2	0.1	1.6	150.4	3.9	0.6	0.5	15.1	2.8	0.1	0.0	3.4	0.0	13.5	0.1	0.0	50.5	1.7	21.1	1.3	3.3	0.0	0.1	42.1	0.0	0.0	0.0	3.8	0.5	0.0	1.6	0.0	0.4	0.0	0.0	0.3	6.3	0.2	0.2	0.2	0.1	16.6	42.2	6.9	8.0	18.5	0.1	0.1	0.1	12.5	0.0	6.7	2.9	1.3	0.9	1.6	0.8	1.6	1.7	1.6	1.3	0.5	2.9	2.1	1.9	1.7	1.3	0.8	3.0	1.1	0.2	1.4	3.1	3.1	1.7	2.3	2.8	3.0	1.0	7.2	3.3
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853622	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA029325: AB_2672998"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.5	5.2	5.8	0.3	17.7	0.4	1.7	2.0	13.8	9.3	0.5	0.0	0.0	0.5	1.3	1.0	0.4	6.7	0.3	0.5	6.3	3.4	0.7	0.5	0.8	0.3	1.4	4.8	0.5	0.5	0.6	8.6	0.7	4.2	0.5	0.6	1.4	3.1	0.9	0.5	2.5	0.4	0.9	2.5	0.3	0.4	2.9	0.5	0.0	0.4	0.0	0.5	1.5	0.2	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.0	1.0	0.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.1	0.2	0.0	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	5.8	17.7	2.0	13.8	6.3	3.4	1.4	4.8	4.2	0.5
CHRDL2	BNF1	ENSG00000054938	"Chordin like 2"	Q6WN34	11	74696429-74731385	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 76.5;gallbladder: 109.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;PC-3: 3.1;SiHa: 6.0;TIME: 2.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA021771	Uncertain				"Secreted to extracellular matrix"	5600000	5600000			"HPA021771: AB_1846689"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (9.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.58e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (6.08e-4)"	1.0	0.0	0.0	39.3	0.2	0.0	1.7	0.1	0.3	64.5	27.9	0.1	1.0	1.4	76.5	47.6	4.3	2.9	109.2	35.8	0.1	0.1	1.0	14.5	0.8	0.5	0.0	0.0	6.7	1.0	0.4	0.1	1.5	0.4	8.0	0.9	0.9	0.2	3.5	2.6	0.3	3.5	45.3	0.6	0.8	24.1	7.6	0.0	0.1	0.2	3.2	1.1	22.6	8.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	6.0	0.7	0.0	1.2	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	3.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	6.0	0.0	0.1	0.0	0.0	2.1	0.0	0.2	0.0	0.5	0.4	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.4	0.0
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120372036	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 87.4"	"Group enriched"	"Detected in some"	6	"ASC TERT1: 18.0;RH-30: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	2000000	2000000	Vesicles	Vesicles	"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavourable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.01e-4)"	20.0	3.3	0.8	20.8	0.9	0.0	21.6	0.7	0.9	87.4	13.9	1.0	9.6	1.3	64.6	39.2	20.0	15.6	38.6	27.8	0.8	1.0	8.3	5.0	8.8	4.5	1.1	1.1	62.1	4.4	1.1	1.8	30.8	3.0	41.7	10.5	4.2	21.8	5.8	7.6	5.4	12.2	45.2	6.5	15.4	10.1	13.3	0.4	1.1	15.7	32.5	9.9	30.4	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	18.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.6	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	5.2	0.1	0.0	4.6	0.1	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.4	0.0	0.0	47.8	0.1	2.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	0.9	0.8	1.0	1.1	1.1	3.0	0.4
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50183289-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 415.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 89.7;BJ: 172.4;fHDF/TERT166: 260.2;HSkMC: 131.8;U-138 MG: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA011795	Approved		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	58000000	58000000	Cytosol	Cytosol	"HPA011795: AB_1847088"	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavourable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	30.2	5.7	0.7	28.2	4.0	0.1	31.7	0.6	0.9	415.7	25.7	1.6	23.9	3.0	121.8	70.9	17.4	33.0	110.3	43.9	0.7	0.1	7.5	4.6	18.8	38.5	0.7	1.2	73.6	10.5	1.0	10.7	89.1	2.2	31.5	4.0	9.2	9.1	21.0	11.0	35.5	10.6	88.0	1.3	13.7	15.0	44.6	0.7	7.7	6.7	15.5	8.7	67.3	49.7	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.2	0.9	0.1	36.9	89.7	1.5	172.4	46.8	43.0	27.0	3.4	0.8	0.0	0.4	260.2	0.5	0.4	0.1	7.7	0.2	0.3	0.0	4.3	0.2	70.3	0.0	0.0	131.8	2.5	52.5	0.2	0.0	0.1	0.0	21.6	0.4	0.0	0.0	0.9	0.5	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.3	0.2	0.0	2.2	0.0	0.0	140.1	30.6	20.9	0.8	0.1	0.3	0.0	10.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.6	0.9	0.7	0.1	0.7	1.2	2.2	0.7
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 150.8;ASC TERT1: 181.0;BJ: 148.1;BJ hTERT+: 108.7;fHDF/TERT166: 501.0;HSkMC: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	21000000	21000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	55.8	150.8	181.0	0.0	148.1	108.7	24.4	32.5	0.0	0.1	0.0	0.1	501.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	157.1	0.0	19.2	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	62.2	0.0	38.5	4.2	0.0	0.0	0.0	15.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155560-114312511	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9;cervix, uterine: 41.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.6;Hep G2: 24.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 56.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	23	"cerebellum: 141.7"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"					"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavourable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	4.7	4.2	6.0	4.2	4.6	0.1	4.1	56.9	5.7	41.9	4.4	2.6	5.7	2.9	25.9	17.0	3.6	6.4	6.3	3.3	4.9	1.7	11.0	16.5	4.4	2.9	5.8	1.8	13.1	12.9	0.7	2.2	9.0	8.6	9.8	1.0	9.6	4.1	11.3	4.0	11.9	3.5	8.4	7.3	3.0	9.7	2.7	5.1	2.8	6.1	5.2	3.2	5.7	17.9	0.9	0.4	2.0	0.2	0.5	0.3	0.1	1.9	4.1	9.6	3.5	0.7	1.0	29.6	4.6	3.1	3.4	2.8	4.2	0.1	0.0	1.1	2.2	4.8	3.3	4.3	1.8	0.0	0.4	0.0	3.4	24.9	1.0	0.0	10.7	2.7	1.2	4.1	1.8	5.0	0.0	1.0	1.9	0.9	0.0	1.8	3.4	1.1	13.3	9.7	1.8	7.9	2.2	0.1	0.1	0.2	0.1	0.5	0.8	3.0	4.6	3.0	6.0	0.4	7.1	0.5	0.0	0.0	2.4	0.0	4.5	0.6	0.2	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.1	0.9	0.3	0.2	2.0	0.5	0.1	0.4	0.2	0.1	6.0	4.6	56.9	5.7	4.9	1.7	5.8	1.8	8.6	5.1
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974320-189012746	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 304.2;endometrium 1: 208.0"	"Cell line enhanced"	"Detected in some"		"AF22: 80.2;ASC diff: 148.6;ASC TERT1: 258.7;fHDF/TERT166: 104.0;HHSteC: 102.2;HSkMC: 192.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	16000000	16000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	41.7	9.7	0.7	34.1	3.4	0.0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208.0	82.0	31.3	32.3	116.3	41.0	1.0	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32.0	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.2	3.1	148.6	258.7	0.0	32.2	28.8	14.1	12.7	0.4	0.0	0.0	0.0	104.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	13.6	0.0	102.2	0.1	0.0	192.4	0.0	17.1	2.8	0.7	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.4	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	1.7	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.8	1.2	1.0	0.3	1.3	1.1	3.2	0.7
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641774-134844843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 110.7"	"Cell line enhanced"	"Detected in many"		"BJ: 71.5;fHDF/TERT166: 66.4;HeLa: 47.4;HHSteC: 45.1;SiHa: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	12000000	12000000	Vesicles	Vesicles	"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	11.5	4.2	1.5	13.7	1.4	0.0	9.5	3.0	1.2	110.7	20.9	1.4	11.8	3.6	42.1	24.1	12.3	20.5	31.8	12.2	1.8	0.9	4.3	3.4	13.4	7.8	3.0	1.3	19.5	3.7	3.7	2.6	53.8	2.2	23.3	4.7	9.1	5.1	9.9	5.0	6.9	8.7	26.7	1.5	6.5	12.5	9.5	1.1	2.7	4.1	10.1	4.0	21.8	22.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	2.1	3.4	32.1	34.6	1.3	71.5	14.4	12.2	13.1	0.0	0.0	0.0	15.8	66.4	0.9	0.0	0.0	3.5	0.0	0.1	0.0	47.4	0.0	45.1	0.0	0.4	33.9	0.0	11.8	0.9	14.5	0.0	0.2	6.4	0.6	0.0	0.1	1.2	1.3	2.5	8.3	0.2	0.0	0.0	0.9	0.4	47.1	0.3	0.0	0.1	0.0	24.7	25.7	10.6	31.4	14.9	0.0	0.0	0.0	20.4	0.0	4.3	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	3.0	1.2	1.8	0.9	3.0	1.3	2.2	1.1
COLEC12	"CL-P1, SCARA4, SRCL"	ENSG00000158270	"Collectin subfamily member 12"	Q5KU26	18	316740-500722	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 40.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.3;BJ: 8.4;HSkMC: 14.3;U-2197: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047917, HPA071056"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cell Junctions"		550000	550000	"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA047917: AB_2680208, HPA071056: AB_2686338"	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (3.01e-3)"	14.2	3.7	6.9	4.6	9.7	1.2	9.4	3.5	6.4	40.8	8.0	7.7	5.1	3.4	13.1	9.9	7.5	6.6	8.1	13.5	7.0	6.3	2.7	1.4	18.7	13.9	8.1	5.8	6.8	2.4	1.5	1.5	32.0	10.5	9.6	5.0	23.5	4.8	3.5	6.3	4.4	5.0	14.3	5.2	1.2	5.0	5.0	4.7	0.7	7.6	3.8	4.9	15.0	7.3	0.9	0.9	3.3	0.8	0.7	0.5	0.3	0.0	0.0	1.5	0.0	1.6	17.3	0.6	8.4	2.9	1.2	2.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	4.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.8	0.4	0.5	0.3	0.3	0.5	0.5	0.4	0.2	0.9	0.4	0.4	3.3	0.7	0.5	0.9	0.3	0.3	6.9	9.7	3.5	6.4	7.0	6.3	8.1	5.8	10.5	4.7
CRYGS	CRYG8	ENSG00000213139	"Crystallin gamma S"	P22914	3	186538441-186546702	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 15.1;cervix, uterine: 21.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035103, HPA063539"	Supported		Uncertain	Cytosol				Cytosol	Cytosol	"HPA035103: AB_10696367, HPA063539: "	"unprognostic (5.52e-4)"	"unprognostic (1.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.72e-9)"	"unprognostic (1.10e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.67e-1)"	"prognostic favourable (2.73e-4)"	1.6	1.9	3.6	1.8	2.7	4.0	3.4	15.1	3.3	21.8	1.8	3.5	1.6	1.7	2.7	3.8	1.6	1.3	1.6	1.6	4.1	4.1	2.2	1.8	2.6	4.2	4.2	1.6	2.2	1.8	1.9	1.6	1.6	3.0	1.6	3.7	5.8	1.8	2.9	1.6	3.0	1.8	2.3	3.2	3.6	2.4	1.8	1.6	6.0	1.6	3.2	3.3	1.6	1.6	0.3	0.6	0.2	0.2	0.0	2.1	0.1	1.0	2.0	3.7	3.1	3.6	5.6	0.5	0.5	1.2	1.3	2.5	0.4	1.5	3.8	4.1	2.7	3.2	1.7	2.8	5.5	3.2	4.9	5.0	1.4	1.9	1.4	2.9	3.4	5.9	3.8	1.2	2.1	4.2	1.0	2.2	3.0	1.2	2.6	1.5	0.2	1.6	4.3	0.8	1.8	1.5	2.3	1.7	1.6	2.6	2.5	1.0	2.0	1.7	4.5	1.4	1.1	1.6	2.7	4.6	2.3	5.3	1.9	1.9	2.7	0.0	0.2	0.0	1.4	0.0	2.1	0.3	1.9	0.8	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.6	0.2	0.1	3.6	2.7	15.1	3.3	4.1	4.1	4.2	1.6	3.0	1.6
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 27.9;lung: 60.9"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 19.5;U-87 MG: 76.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (3.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (8.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.80e-3)"	12.4	1.5	1.0	13.8	1.3	3.0	2.8	0.8	1.6	27.9	3.0	1.4	0.0	0.2	2.3	2.2	5.9	2.9	2.1	6.9	1.1	1.0	0.2	0.5	60.9	0.5	1.2	0.1	3.3	4.1	0.2	3.8	2.6	7.4	4.3	0.7	1.6	0.6	0.3	20.6	0.4	1.4	1.6	2.6	1.0	2.0	1.1	1.2	0.1	0.7	8.8	7.0	7.2	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	3.1	2.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.3	0.8	1.6	1.1	1.0	1.2	0.1	7.4	1.2
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023568-47050751	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 38.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;CACO-2: 6.1;HEK 293: 2.5;NTERA-2: 2.8;SCLC-21H: 3.7;T-47d: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA017661	Approved									"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	7.9	3.6	9.0	1.1	14.9	0.5	16.0	7.1	16.9	38.1	2.0	1.6	2.5	2.1	3.6	3.2	12.0	9.7	2.0	6.7	4.8	10.6	6.3	10.0	8.9	2.0	3.3	13.5	1.7	2.0	2.0	4.1	1.5	7.8	8.0	2.3	17.6	23.7	3.4	4.5	5.0	1.8	2.4	2.0	1.0	14.3	4.2	0.9	0.0	4.0	6.9	8.8	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	0.6	0.2	3.7	0.0	0.0	0.3	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9
DEFB103B		ENSG00000177243	"Defensin beta 103B"	P81534	8	7428888-7430348	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 4.1;lymphoid tissue: 6.3"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.7;U-2 OS: 1.2;U-2197: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.1	0.0			0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DIO2	"SelY, TXDI2"	ENSG00000211448	"Iodothyronine deiodinase 2"	Q92813	14	80197527-80387757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 67.7;thyroid gland: 128.7"	"Cell line enhanced"	"Detected in some"		"BJ: 26.1;fHDF/TERT166: 14.3;HeLa: 29.9;HHSteC: 14.9;SiHa: 54.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029544, HPA048002"			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA029544: , HPA048002: AB_2680230"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.67e-4)"	"prognostic favourable (4.62e-6)"	"unprognostic (2.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.15e-2)"	1.3	1.8	13.0	0.9	12.3	0.7	6.1	1.0	19.7	67.7	1.2	1.6	1.9	1.2	15.6	1.1	36.1	0.9	2.5	4.7	14.2	2.7	2.4	0.7	1.2	1.0	4.1	7.6	0.7	1.3	0.9	35.9	5.9	13.2	5.0	1.3	13.1	17.7	12.4	3.0	3.3	1.2	2.4	1.2	0.9	2.5	2.5	1.4	0.0	128.7	15.8	12.0	2.6	13.7	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.4	0.0	26.1	5.5	2.3	0.3	0.0	0.1	0.0	0.1	14.3	0.5	0.9	0.0	1.9	0.0	0.0	0.0	29.9	0.0	14.9	0.0	0.0	1.6	0.0	0.5	0.0	0.5	0.0	0.2	0.1	0.6	0.0	0.0	0.5	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.0	54.7	11.4	0.1	0.0	0.0	0.3	0.1	2.4	5.5	6.6	0.8	0.0	0.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	13.0	12.3	1.0	19.7	14.2	2.7	4.1	7.6	13.2	1.4
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 40.9;placenta: 17.6"	"Cell line enriched"	"Detected in single"	39	"AF22: 34.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 8.1"												"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	4.5	0.2	0.2	1.7	1.8	0.0	3.5	0.1	0.8	40.9	1.6	0.1	1.0	0.0	3.4	2.2	1.9	3.5	2.9	1.6	0.7	0.0	0.9	2.7	1.4	7.1	0.1	0.1	9.2	4.1	0.0	0.6	17.6	0.3	1.6	0.4	12.6	0.8	2.5	2.2	1.9	0.7	0.9	0.1	2.5	0.7	1.0	0.1	0.1	3.6	1.1	0.4	6.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	34.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.1	0.6	0.7	0.0	0.1	0.1	0.3	0.1
DKK2		ENSG00000155011	"Dickkopf WNT signaling pathway inhibitor 2"	Q9UBU2	4	106921802-107283806	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 21.7"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB009727, HPA052611"	Uncertain		Supported	"Golgi apparatus"	"Secreted in other tissues"			"Golgi apparatus"	"Golgi apparatus"	"CAB009727: AB_2091492, HPA052611: AB_2732576"	"unprognostic (3.14e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.58e-2)"	6.6	1.2	3.0	1.5	2.5	0.0	4.8	1.8	3.6	21.7	3.6	0.2	0.0	0.1	1.4	2.4	2.0	0.9	1.6	3.1	2.9	2.2	0.4	0.3	7.9	0.9	2.0	1.5	6.3	0.3	0.9	3.4	3.4	2.5	2.9	0.7	6.8	2.7	2.4	2.4	6.1	0.5	0.9	2.3	1.7	0.4	0.5	0.2	0.1	1.3	4.4	3.7	1.1	2.6	0.0	0.2	0.0	0.1	0.0	3.0	0.0	0.0	0.0	3.6	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	2.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.5	1.8	3.6	2.9	2.2	2.0	1.5	2.5	0.2
EDNRA		ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 62.6;seminal vesicle: 52.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.2;ASC TERT1: 14.2;HHSteC: 7.3;LHCN-M2: 16.8;SH-SY5Y: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Uncertain	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (1.50e-7)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	7.6	2.6	1.3	1.4	1.8	0.0	7.2	0.6	2.4	62.6	2.6	1.0	21.7	1.5	37.3	14.2	4.7	13.3	7.3	15.1	1.3	1.3	3.1	1.4	12.7	2.0	1.8	1.0	23.5	0.9	1.9	2.2	5.9	2.7	21.5	1.5	10.3	4.1	52.3	4.8	3.2	1.8	19.4	1.6	11.5	4.4	9.1	1.4	2.9	5.0	6.0	2.6	14.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.1	0.0	7.2	14.2	0.0	2.1	2.8	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.5	0.2	0.0	1.5	0.0	2.4	0.0	7.3	0.0	0.0	5.5	0.4	0.4	0.0	0.0	0.0	1.1	16.8	0.2	0.0	0.1	1.2	0.8	0.0	0.7	0.1	1.1	0.8	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.6	0.0	0.0	1.1	0.3	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.6	2.4	1.3	1.3	1.8	1.0	2.7	1.4
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387156-40428619	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.2;pancreas: 37.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 12.4;hTCEpi: 8.4;RT4: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.6	2.2	5.7	1.7	25.9	0.5	2.1	5.4	15.8	26.2	3.3	0.6	1.9	1.7	4.0	4.4	7.5	1.3	3.6	1.4	4.9	6.3	3.6	0.5	4.8	0.9	4.0	6.3	2.6	37.3	1.7	4.2	2.9	14.5	5.3	3.6	2.8	21.2	5.1	1.7	3.2	1.6	2.5	1.7	5.1	8.8	1.3	4.8	0.0	7.0	5.6	4.8	13.7	2.9	0.5	7.4	1.4	0.3	0.9	0.8	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	3.7	0.0	12.4	0.3	0.7	0.4	0.7	0.5	0.2	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.1	0.1	1.1	0.1	0.0	0.3	1.5	17.9	1.9	0.4	0.8	1.4	0.3	0.6	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.3	0.0	1.0	0.1	0.1	1.4	0.2	0.0	0.2	0.3	0.8	0.3	0.2	0.3	0.0	0.5	0.6	0.6	0.0	0.9	0.2	7.4	0.6	0.1	5.7	25.9	5.4	15.8	4.9	6.3	4.0	6.3	14.5	4.8
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720800-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3"	"Group enriched"	"Detected in some"	7	"BEWO: 3.5;Hep G2: 13.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 4.4"	"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB010336	Supported				"Secreted to blood"					"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	10.9	0.0	0.0	0.0	0.0	8.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.8	29.3	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.7	0.0	1.6	0.0	0.7	0.9	1.6	0.0	0.7	0.0	0.6	0.0	0.0	0.0	2.4	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	1.1	0.1	0.0	0.0	13.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.4
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 64.5;endometrium 1: 68.9"	"Group enriched"	"Detected in some"	9	"MCF7: 24.3;T-47d: 31.5"	"Group enriched"	"Detected in many"	9	"breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favourable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	3.0	0.9	0.5	1.6	0.5	0.2	16.2	0.8	0.4	64.5	1.5	0.2	2.2	0.1	68.9	27.7	1.1	26.7	1.9	1.1	0.5	0.8	1.5	6.6	3.6	1.6	0.4	0.1	14.2	0.4	0.0	9.3	0.9	0.6	3.6	0.1	2.6	1.6	4.1	2.0	0.6	0.5	20.8	0.4	1.6	0.3	1.9	0.4	1.9	1.3	2.2	2.5	3.8	23.7	0.6	1.0	0.0	0.8	0.3	2.5	1.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.0	24.3	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	31.5	0.0	0.0	0.1	0.1	0.3	0.0	2.9	0.5	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.3	0.2	1.0	0.6	1.3	0.4	1.0	0.4	2.5	0.9	0.0	0.3	0.0	0.0	0.3	1.0	0.5	0.5	0.8	0.4	0.5	0.8	0.4	0.1	0.6	0.4
EVX2		ENSG00000174279	"Even-skipped homeobox 2"	Q03828	2	176077472-176083913	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.4;prostate: 3.8;seminal vesicle: 5.0;testis: 6.1;vagina: 2.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;SCLC-21H: 1.5;SH-SY5Y: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.6;pons and medulla: 1.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 0.8"	HPA041576	Uncertain									"HPA041576: AB_10796347"		"unprognostic (2.27e-1)"	"unprognostic (1.68e-3)"		"unprognostic (1.83e-1)"				"unprognostic (3.41e-1)"	"unprognostic (5.75e-1)"		"unprognostic (3.13e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.32e-1)"		"unprognostic (4.93e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.9			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		3.8	1.8		0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 47.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 13.4;SCLC-21H: 20.4;U-266/70: 38.0;U-266/84: 46.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"B-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favourable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	10.5	2.0	6.5	2.6	7.4	0.8	13.4	2.4	6.5	47.4	6.4	3.8	21.0	1.0	15.7	10.7	25.9	28.2	2.2	4.3	7.0	4.1	5.2	1.8	2.3	1.3	6.3	4.9	5.2	2.4	11.5	4.7	5.9	9.1	18.5	3.2	15.4	28.6	27.3	2.1	4.2	1.1	2.3	7.2	1.1	8.2	4.9	5.1	14.3	21.4	3.6	14.0	5.5	17.3	2.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	13.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	20.4	0.0	0.0	9.1	0.0	1.8	0.0	0.0	0.0	1.6	0.1	3.0	38.0	46.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	7.4	2.4	6.5	7.0	4.1	6.3	4.9	9.1	5.1
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947140	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3"	"Cell line enhanced"	"Detected in some"		"A-431: 5.4;fHDF/TERT166: 6.3;HEL: 9.0;hTCEpi: 8.3;K-562: 9.2;SiHa: 6.4;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA069613	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	Nucleoplasm	"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	1.5	0.3	0.0	1.2	0.0	0.0	0.3	1.0	13.9	0.0	0.6	0.0	0.0	10.0	0.4	0.1	6.4	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.4	55.5	0.6	15.3	13.1	1.4	0.8	0.2	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	2.1	0.3	3.9	0.1	0.0	1.7	0.2	0.0	0.4	0.1	0.0	0.4	0.0	2.6	6.3	1.2	0.0	0.0	0.1	0.0	0.0	9.0	1.1	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	9.2	0.0	3.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	6.4	0.0	0.0	0.0	6.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.3	1.0	0.4	0.2	0.3	0.4	0.8	0.2
GDF7	BMP12	ENSG00000143869	"Growth differentiation factor 7"	Q7Z4P5	2	20666664-20679245	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 13.3;seminal vesicle: 22.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;Hep G2: 6.2;RT4: 11.9;SH-SY5Y: 4.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.6;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	8	"B-cells: 2.6"	"Region enhanced"	"Detected in single"		"amygdala: 0.3"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (1.35e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.10e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.63e-3)"	"unprognostic (6.31e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.02e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-3)"	0.3	0.3	0.4	1.5	0.5	0.0	0.2	0.5	1.3	13.3	0.4	0.2	4.7	0.0	6.8	3.1	0.9	0.6	1.8	2.4	0.2	0.2	3.3	7.2	0.5	3.1	2.9	0.9	0.4	0.8	0.0	0.6	2.3	0.4	3.6	0.0	2.4	1.1	22.0	0.6	1.5	1.5	1.0	0.2	3.2	0.7	0.7	1.2	0.2	0.2	0.0	1.5	1.6	6.0	2.6	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	1.8	11.9	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.5	0.5	1.3	0.2	0.2	2.9	0.9	0.4	1.2
GLYATL2	"BXMAS2-10, MGC24009"	ENSG00000156689	"Glycine-N-acyltransferase like 2"	Q8WU03	11	58834065-58904215	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.8;BJ hTERT+ SV40 Large T+ RasG12V: 4.1;HAP1: 6.5;SK-BR-3: 15.5;U-2197: 7.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.7;endometrial cancer: 15.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"					"Not detected"	"Not detected"			"HPA060292, HPA065454"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA060292: AB_2684245, HPA065454: "	"unprognostic (1.02e-2)"	"unprognostic (3.79e-3)"	"unprognostic (8.11e-4)"	"prognostic favourable (9.05e-7)"	"unprognostic (1.05e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-5)"	"unprognostic (7.79e-3)"	"unprognostic (8.28e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.31e-2)"	0.4	0.0	0.4	0.1	0.2	0.0	11.2	0.1	0.3	18.8	0.1	0.1	0.1	0.1	1.2	0.1	0.8	0.1	6.6	0.2	0.3	0.4	0.1	0.1	0.6	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.0	0.1	25.8	0.1	0.1	1.2	0.1	0.1	1.5	1.1	0.1	0.1	0.1	0.1	0.1	4.4	9.9	0.1	0.3	0.4	0.1	2.1	0.4	0.2	0.2	0.9	0.0	0.0	0.5	0.0	0.9	3.0	0.0	1.9	5.8	2.5	4.1	0.0	0.0	0.2	0.0	1.6	0.5	6.5	0.0	2.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.2	15.5	0.0	0.0	0.0	0.0	2.1	0.1	7.5	2.2	0.0	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.1	2.1	0.2	0.0	0.1	0.0	0.9	0.4	0.2	0.1	0.3	0.3	0.4	0.6	0.1	0.1	0.1
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170591-27180261	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 48.2;endometrium 1: 45.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 54.8;THP-1: 28.8;U-937: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 7.8;NK-cell: 12.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;NK-cells: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB019384	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"CAB019384: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	5.9	2.7	0.3	4.6	0.4	1.2	2.5	0.3	0.3	48.2	15.9	0.3	4.0	0.0	45.6	5.4	0.3	3.4	0.5	0.3	0.3	0.0	7.9	0.3	0.3	0.5	0.3	0.3	1.3	0.3	0.0	0.3	7.7	0.3	22.2	5.3	0.3	0.6	6.6	28.0	2.4	3.1	19.2	0.4	0.3	0.0	3.4	0.3	2.2	0.3	0.3	0.3	19.0	7.6	0.2	1.2	7.8	0.1	12.7	2.3	0.3	6.0	1.3	0.0	18.3	9.3	8.9	0.0	12.1	8.3	5.6	5.2	1.8	5.4	0.0	3.4	9.5	6.8	4.7	0.0	4.1	2.8	54.8	6.4	4.7	0.1	0.2	2.8	9.7	5.6	0.3	0.4	0.0	8.4	0.2	0.0	4.0	0.0	0.0	18.6	0.0	5.7	0.5	1.2	0.0	10.7	2.9	14.5	0.0	4.2	0.0	0.0	0.0	28.8	0.0	0.0	5.0	6.5	0.0	0.1	0.0	0.0	0.0	29.9	0.1	7.8	0.1	0.3	2.3	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.0	0.0	0.0	12.7	0.0	0.4	0.0	0.3	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181510-27185223	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;HEK 293: 24.6;THP-1: 17.6;U-937: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	1.5	0.4	0.0	1.7	0.0	0.0	2.0	0.0	0.0	35.7	9.3	0.0	5.7	0.0	60.9	8.8	0.0	0.7	0.0	0.2	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	9.0	0.0	16.5	2.4	0.0	0.1	6.3	4.9	0.7	0.2	27.3	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	20.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.0	6.7	8.2	5.8	0.0	14.5	17.5	10.3	7.4	0.1	0.8	0.0	3.3	12.2	1.6	8.6	0.0	7.5	0.8	24.6	3.0	6.0	0.3	0.5	6.1	0.8	3.7	0.3	0.0	0.0	7.4	0.1	0.0	1.1	0.1	0.0	4.7	0.0	7.2	0.3	0.0	0.1	4.9	4.2	3.2	0.0	3.5	0.0	1.0	0.6	17.6	0.0	0.1	7.1	1.6	0.7	0.0	0.0	0.0	0.1	22.9	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200106	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 48.5;prostate: 25.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.2;HEK 293: 21.1;PC-3: 10.5;RT4: 23.5;THP-1: 10.0;U-937: 11.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA069061			Supported	"Nucleoplasm,Intermediate filaments"				Nucleoplasm	Nucleoplasm	"HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	48.5	6.9	0.0	7.1	0.0	5.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	16.5	0.0	25.1	8.6	0.0	0.1	17.9	1.2	0.4	0.1	15.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	12.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	1.4	0.1	0.0	0.0	7.4	8.2	2.9	1.9	1.5	0.1	0.0	0.9	3.5	0.0	15.2	0.0	2.5	0.0	21.1	1.0	4.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	10.5	1.5	0.3	0.0	0.0	23.5	0.4	0.0	1.8	0.0	0.1	0.0	10.0	0.0	0.2	2.7	0.1	0.1	0.0	0.0	0.0	0.0	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HOXD13	"HOX4I, SPD"	ENSG00000128714	"Homeobox D13"	P35453	2	176092891-176095938	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0"	"Group enriched"	"Detected in some"	4	"HAP1: 9.6;HEK 293: 27.6;HL-60: 30.7;NB-4: 18.3;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064064			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064064: AB_2685186"	"unprognostic (2.04e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (2.52e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.08e-2)"		"unprognostic (4.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.66e-1)"		"unprognostic (1.01e-2)"	"unprognostic (2.82e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.70e-2)"		"unprognostic (9.98e-3)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	14.0	13.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	13.8	8.8	0.1	0.1	19.0	0.6	0.0	0.1	3.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	3.8	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	1.5	0.0	27.6	4.2	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	18.3	0.9	1.5	0.0	0.1	0.0	0.0	0.2	8.0	1.9	1.9	0.0	4.4	0.0	0.0	0.0	1.0	0.0	0.4	2.5	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
HPSE2	"HPA2, HPR2, UFS"	ENSG00000172987	"Heparanase 2 (inactive)"	Q8WWQ2	10	98457077-99235862	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 31.0;smooth muscle: 22.2"	"Group enriched"	"Detected in some"	19	"BJ hTERT+: 12.0;HEL: 22.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.3;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044603	Uncertain				"Secreted to extracellular matrix"					"HPA044603: AB_10794051"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-3)"	"unprognostic (4.83e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.13e-3)"	1.6	0.1	2.0	4.1	9.7	0.1	5.5	2.7	4.2	31.0	3.1	5.4	0.9	3.4	8.0	0.2	17.2	2.3	2.1	0.1	1.7	8.3	1.4	0.1	2.4	0.1	12.2	1.4	0.2	0.1	0.1	0.2	1.7	12.4	12.1	3.2	0.4	1.0	4.9	0.2	1.4	5.1	22.2	11.9	0.1	2.5	2.2	7.6	0.0	0.2	0.2	0.4	12.4	12.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	12.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	2.0	9.7	2.7	3.1	1.7	8.3	12.2	1.4	12.4	7.6
IBSP	"BSP, BSP-II, SP-II"	ENSG00000029559	"Integrin binding sialoprotein"	P21815	4	87799581-87812435	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2"	"Cell line enriched"	"Detected in some"	6	"U-138 MG: 12.6"	"Cancer enhanced"	"Detected in many"		"glioma: 12.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (2.53e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.75e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.03e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.02e-3)"		"unprognostic (5.81e-11)"	"unprognostic (6.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.11e-1)"	0.2	0.0	1.9	0.6	0.4	1.0	0.1	2.0	4.5	4.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.8	1.3	1.0	0.1	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.8	6.2	1.1	2.6	0.4	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	2.0	1.5	1.0	0.1	0.9	0.0	2.6	0.0
ITGA11	HsT18964	ENSG00000137809	"Integrin subunit alpha 11"	Q9UKX5	15	68296533-68432162	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.9;U-138 MG: 46.5;WM-115: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 6.1"	HPA051813	Uncertain					42000	42000			"HPA051813: AB_2681622"	"unprognostic (4.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.22e-7)"	"unprognostic (8.38e-3)"	"unprognostic (2.28e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.33e-2)"	4.5	2.9	0.4	3.5	0.9	0.0	2.9	0.5	3.6	41.9	1.5	0.9	3.5	0.6	59.6	11.4	2.6	8.0	3.4	9.0	0.5	0.5	4.9	0.7	1.3	0.5	0.8	0.5	15.7	0.8	0.2	1.5	2.2	1.3	4.5	1.4	1.5	0.9	8.9	1.9	2.1	1.6	30.2	0.9	4.0	1.3	3.4	0.7	0.2	1.8	5.8	0.7	5.6	7.4	1.7	1.3	1.8	1.0	0.8	1.5	0.1	0.0	0.0	0.1	0.2	2.2	0.0	0.0	4.4	8.6	1.0	0.3	0.0	0.0	0.0	0.3	66.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.6	0.0	5.9	0.0	3.7	0.8	0.0	1.9	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	2.7	46.5	0.3	0.9	0.0	0.0	0.0	0.0	6.9	0.0	25.8	1.6	1.0	0.9	1.2	0.9	1.5	0.8	1.1	1.0	0.7	1.7	1.3	1.2	1.8	0.8	0.8	1.3	1.0	0.1	0.4	0.9	0.5	3.6	0.5	0.5	0.8	0.5	1.3	0.7
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favourable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2"	"Cell line enriched"	"Detected in some"	4	"BJ: 64.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles		170000000	170000000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA055194: AB_2682733, HPA072208: AB_2686494"		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	64.5	2.8	7.7	15.3	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.9	8.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473785	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 564.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavourable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	109.4	0.2	0.0	0.0	0.2	1.1	0.2	125.8	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.3	0.2	0.2	2.7	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	244.2	6.7	0.2	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9"	"Cell line enriched"	"Detected in single"	55	"hTCEpi: 41.5"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"	62000000	62000000			"HPA063474: AB_2685019"	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	0.2	0.0	0.2	0.2	0.2	0.1	29.4	0.2	0.2	110.5	0.2	0.2	0.2	0.0	8.2	0.2	5.7	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.2	0.0	0.2	11.3	0.2	1.4	326.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	234.9	5.5	0.2	77.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LCE3D	"LEP16, SPRL6A, SPRL6B"	ENSG00000163202	"Late cornified envelope 3D"	Q9BYE3	1	152579381-152580504	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5"	"Group enriched"	"Detected in some"	6	"hTCEpi: 8.5;hTERT-HME1: 7.9"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 126.9;melanoma: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.34e-1)"				"unprognostic (1.09e-1)"			"unprognostic (2.87e-1)"									0.3	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	53.2	0.1	0.1	0.1	0.0	3.7	0.1	7.8	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	8.5	0.1	0.1	17.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.9	0.1	96.6	48.6	0.1	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	7.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LCE3E	LEP17	ENSG00000185966	"Late cornified envelope 3E"	Q5T5B0	1	152565654-152566772	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 35.6;lymphoid tissue: 21.3;tongue: 38.9;vagina: 19.8"	"Cell line enriched"	"Detected in single"	6	"hTCEpi: 4.9"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 40.7;melanoma: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.33e-1)"				"unprognostic (7.76e-2)"			"unprognostic (2.51e-1)"									0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.9	0.1	9.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	3.5	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	38.9	21.3	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159906690-159916530	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 1.9"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 13.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	25	"amygdala: 40.1;basal ganglia: 26.8;cerebral cortex: 31.9;hippocampal formation: 71.0"	"Group enriched"	"Detected in many"	7	"amygdala: 8.6;cerebral cortex: 13.2;hippocampal formation: 26.9"												"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.1	0.0	0.9	0.0	0.0	0.8	0.0	0.0	4.5	1.9	0.0			0.0	0.3	0.7	0.0	0.3	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.7	0.0		0.4	0.0	0.0	0.0	0.0		0.2	0.0		0.2	1.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.3			0.0		0.0	0.0	1.0	0.5	0.3	1.5	0.2	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.5	0.1	1.5	0.2	0.3	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	1.5	0.3	0.1	0.3	0.1	0.1										
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 7.5;epididymis: 4.0"	"Cell line enriched"	"Detected in single"	39	"HEL: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	7.5	1.3			0.4	1.2	4.0	2.1	0.2	1.2	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.8	1.1		1.5	0.3	0.2	1.7	1.5	1.1	0.0	0.0	0.5	0.3			0.0		0.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Group enriched"	"Detected in some"	8	"BJ: 26.5;BJ hTERT+: 101.0"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	1800000000	1800000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA001617: AB_1079314, HPA009641: "	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favourable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	26.5	101.0	0.3	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7
MEX3B	"DKFZp434J0617, RKHD3, RNF195"	ENSG00000183496	"Mex-3 RNA binding family member B"	Q6ZN04	15	82041778-82046141	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 15.6;testis: 33.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.7;HEL: 24.0;SH-SY5Y: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041093	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA041093: "	"unprognostic (2.42e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.93e-8)"	"unprognostic (1.24e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.51e-2)"	2.0	0.6	1.5	1.8	1.6	2.0	1.6	3.8	4.5	15.6	2.8	1.6	2.5	0.8	7.9	0.6	1.1	1.2	2.8	2.0	2.0	1.4	1.0	1.0	1.4	2.8	2.2	3.3	6.8	0.7	0.2	0.9	3.3	1.0	3.7	0.9	1.2	3.0	3.8	1.6	1.1	1.1	4.0	1.0	1.2	1.0	33.3	0.7	8.4	1.0	1.8	1.2	3.1	4.2	0.0	1.3	0.0	0.1	0.4	0.1	0.0	0.1	1.2	8.6	32.7	0.7	1.0	2.5	1.0	0.5	1.8	1.6	0.2	0.1	1.5	0.6	1.9	0.2	4.1	0.1	1.3	0.3	2.7	24.0	1.4	1.0	1.4	0.2	7.6	0.5	0.6	1.0	2.0	3.7	1.1	0.0	3.1	0.8	3.9	2.0	11.2	0.3	5.5	5.2	0.8	0.0	0.0	6.9	13.4	1.7	0.3	1.1	0.1	0.4	3.4	4.5	5.3	2.5	1.5	3.1	1.6	1.8	1.4	2.4	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	1.6	3.8	4.5	2.0	1.4	2.2	3.3	1.0	0.7
MPPED2	"239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638"	ENSG00000066382	"Metallophosphoesterase domain containing 2"	Q15777	11	30384493-30586872	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 31.0;thyroid gland: 30.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 19.4;HAP1: 11.5;RT4: 8.1;SH-SY5Y: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062575			Approved	Nucleoli,Vesicles,Mitochondria				Nucleoli	Nucleoli	"HPA062575: AB_2684797"	"unprognostic (9.60e-3)"	"unprognostic (6.12e-3)"	"unprognostic (3.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-4)"	"unprognostic (6.82e-2)"	"unprognostic (2.47e-7)"	"unprognostic (3.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.57e-2)"	2.9	7.0	6.3	1.7	19.3	1.1	5.5	4.6	8.9	31.0	4.2	1.8	4.4	1.5	8.3	7.9	1.6	11.1	1.9	4.6	8.5	9.7	12.2	1.2	1.1	0.9	7.0	6.7	1.2	2.5	5.0	10.7	2.5	11.2	15.6	1.4	7.1	12.1	10.1	5.7	1.0	1.4	5.1	4.6	3.1	1.9	3.8	3.4	9.1	30.0	1.2	1.0	4.7	4.9	1.3	0.7	0.3	0.2	2.0	4.8	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	11.5	0.0	0.0	0.0	2.1	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	3.2	0.0	0.0	3.1	0.2	0.0	8.1	0.1	6.1	0.0	0.0	3.1	1.8	0.0	0.1	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.9	0.0	4.8	0.0	0.0	0.6	0.4	1.3	1.3	0.2	0.2	2.0	0.0	0.7	0.1	0.2	6.3	19.3	4.6	8.8	8.5	9.7	7.0	6.7	11.2	3.4
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859666-4863936	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 47.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 29.2;EFO-21: 13.6"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB026198: , HPA063895: AB_2685145, HPA073604: "	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favourable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	9.0	3.8	4.6	1.5	2.9	1.0	11.4	1.4	8.6	47.2	1.4	6.0	1.0	1.4	17.9	1.2	1.5	4.5	2.2	2.5	8.7	2.2	1.4	1.3	2.1	1.4	4.2	1.6	2.5	2.0	1.2	11.5	5.1	14.0	3.9	0.9	1.7	3.7	4.9	18.3	2.5	1.2	4.3	3.6	3.3	1.3	1.4	3.8	0.0	4.7	2.6	1.2	5.9	18.8	0.5	0.4	1.9	0.8	0.7	0.6	0.2	1.5	0.9	0.3	1.8	5.2	3.3	5.6	3.7	1.8	2.2	1.1	29.2	9.5	0.1	13.6	2.7	0.0	6.6	0.0	0.8	1.2	7.6	0.0	5.1	10.4	0.4	0.1	0.9	0.6	0.5	1.6	0.5	0.5	4.7	0.2	1.1	0.7	0.8	1.4	0.1	6.9	3.8	4.0	0.3	0.1	0.9	0.3	0.1	3.3	0.1	2.3	0.6	1.3	1.2	2.6	5.7	8.2	6.0	0.6	0.5	3.4	1.7	1.9	2.5	1.9	0.4	0.5	0.3	0.5	0.4	0.5	0.3	0.4	0.3	0.4	0.6	0.4	1.4	0.7	0.8	0.4	0.5	0.2	4.6	2.9	1.4	8.6	8.7	2.2	4.2	1.6	14.0	3.8
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346641	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 49.4;pancreas: 46.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.5;BJ hTERT+: 47.9;fHDF/TERT166: 22.4;HaCaT: 19.9;HSkMC: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000508	Uncertain				"Secreted - unknown location"	1700000	1700000			"HPA000508: AB_2147995"	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (8.94e-4)"	6.5	12.1	0.5	10.4	1.2	0.0	7.5	0.4	0.8	49.4	4.4	0.6	18.8	2.1	11.4	6.0	8.7	4.2	5.8	9.2	0.6	0.5	8.0	4.5	5.9	0.9	0.6	0.7	7.9	46.6	0.5	1.4	7.9	0.8	11.0	5.9	10.2	11.5	29.5	1.1	16.6	7.8	8.8	0.5	7.7	5.1	4.0	0.3	5.7	15.0	11.7	6.2	12.7	9.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	12.5	0.0	7.4	47.9	0.0	0.0	0.0	0.2	0.0	0.6	22.4	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	2.3	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.8	0.6	0.5	0.6	0.7	0.8	0.3
MYOCOS		ENSG00000283683	"Myocilin opposite strand"	A0A1B0GUC4	1	171600621-171638799	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;epididymis: 4.8;fallopian tube: 3.9"	"Cell line enriched"	"Detected in some"	6	"HEL: 24.0"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.0	0.0		0.0		0.1	0.0		0.0	8.1	0.0			0.0	1.3	4.8	0.0	3.9	0.0	0.0			1.1	0.0	0.0	0.0			0.0	0.4	0.0		0.1		0.0	0.0		0.0	0.8	0.1	0.0	0.0	0.0		0.0	0.1	1.1			0.8		0.0	0.3		0.9	0.6	1.6	0.3	0.1	1.3	0.0	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	24.0	0.4	0.4	0.1	0.0	2.7	0.0	0.1	0.0	0.0	0.0	4.2	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.9	1.8	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.2	0.3	0.2	1.0	0.9	0.4	1.1	0.1	0.9	0.5	0.4	1.6	0.1	0.0	0.6	1.3	0.0										
OR1N1	"OR1-26, OR1N3"	ENSG00000171505	"Olfactory receptor family 1 subfamily N member 1"	Q8NGS0	9	122526358-122527296	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 1.2;testis: 1.3"	"Cell line enhanced"	"Detected in some"		"RT4: 1.2;U-266/70: 1.3"	"Group enriched"	"Detected in some"	13	"endometrial cancer: 0.8;ovarian cancer: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																															"unprognostic (3.63e-2)"								0.2	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.2	1.2	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.3		0.3	0.0	0.0	0.0	0.0		0.2	0.2		0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2T4	OR2T4Q	ENSG00000196944	"Olfactory receptor family 2 subfamily T member 4"	Q8NH00	1	248361581-248362627	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;cervix, uterine: 1.1;prostate: 1.2"	"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.0	1.1	0.0			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.7		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR4F4	OR4F18	ENSG00000177693	"Olfactory receptor family 4 subfamily F member 4"	Q96R69	15	101922042-101923095	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"cervix, uterine: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PGBD5	"DKFZp761A0620, FLJ11413"	ENSG00000177614	"PiggyBac transposable element derived 5"	Q8N414	1	230314482-230426371	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.7;NTERA-2: 18.1;RH-30: 9.8;SCLC-21H: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065010			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065010: AB_2685402"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (8.78e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.51e-1)"	0.8	10.8	16.0	0.8	14.1	0.6	0.7	17.9	27.0	21.9	1.5	6.0	0.1	1.0	5.8	0.5	1.8	5.6	2.2	13.3	20.0	8.0	1.5	2.8	1.8	0.9	7.1	8.9	0.9	21.6	0.9	4.0	2.6	8.0	1.4	1.3	1.0	3.2	1.2	2.8	0.9	1.0	3.0	5.0	2.6	1.6	5.8	4.6	0.5	6.0	0.6	5.1	1.6	1.5	0.8	0.6	1.5	0.6	0.6	0.6	0.2	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	4.0	0.0	17.7	1.7	0.0	3.3	1.4	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.1	3.6	18.1	0.1	0.0	9.8	2.8	2.1	0.0	25.0	4.7	0.6	0.0	0.2	0.2	6.1	0.0	0.0	1.5	0.0	1.4	7.6	5.7	0.0	0.0	1.5	0.2	1.5	0.6	1.2	0.6	0.6	0.5	0.4	0.5	0.4	0.4	0.8	0.6	0.6	1.2	0.6	0.6	0.6	0.4	0.2	16.0	14.1	17.9	23.8	20.0	8.0	7.1	8.9	8.0	4.6
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB025879			Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	5.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome				Centrosome	Centrosome	"HPA037583: "	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.3	0.2	9.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	4.3	0.1	1.4	16.9	0.1	0.2	0.1	1.4	0.1	5.8	0.0	0.0	0.3	0.1	0.0	0.3	3.4	0.1	0.0	0.0	0.0	2.0	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2
PMEPA1	"STAG1, TMEPAI"	ENSG00000124225	"Prostate transmembrane protein, androgen induced 1"	Q969W9	20	57648392-57711536	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 60.4;prostate: 67.3"	"Cell line enhanced"	"Detected in many"		"SiHa: 39.5;U-2 OS: 25.8;U-251 MG: 90.8;WM-115: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.2;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	7	"B-cells: 5.2;dendritic cells: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072291			Supported	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA072291: AB_2686509"	"unprognostic (2.72e-3)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (4.73e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.83e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (2.87e-7)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.87e-3)"	"prognostic unfavourable (7.60e-4)"	27.0	7.8	7.5	10.6	34.8	1.3	9.5	2.6	12.6	60.4	10.8	11.0	4.2	4.4	22.1	6.7	7.1	7.7	21.8	10.7	7.5	8.6	5.3	1.7	8.5	4.5	10.2	5.9	6.2	18.6	2.6	5.6	3.0	12.1	67.3	5.7	21.3	11.6	13.3	17.4	6.8	7.6	17.6	8.1	4.0	5.3	3.2	9.1	1.3	5.4	6.0	6.2	8.4	13.0	5.2	18.4	0.1	0.3	0.0	1.6	0.4	5.9	14.5	0.4	0.7	0.4	0.0	0.1	0.9	0.0	0.3	0.1	0.2	18.8	0.0	3.5	1.4	23.0	0.3	19.4	0.2	0.1	0.7	0.0	4.0	0.0	0.3	0.0	0.1	0.2	10.9	0.8	2.4	2.5	0.1	0.2	1.2	12.3	0.7	0.1	1.8	1.8	0.0	7.0	2.1	4.7	0.0	3.4	2.7	39.5	23.5	2.7	3.6	0.7	6.3	3.5	25.8	0.3	90.8	1.1	0.1	0.0	1.6	0.2	45.8	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.6	0.2	0.0	5.2	1.6	0.9	0.1	0.0	0.0	18.4	0.4	0.4	7.5	34.8	2.6	12.6	7.5	8.6	10.2	5.9	12.1	9.1
PRLHR	"GPR10, PrRPR"	ENSG00000119973	"Prolactin releasing hormone receptor"	P49683	10	118589989-118595699	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1"	"Cell line enriched"	"Detected in single"	9	"SH-SY5Y: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA039361	Enhanced									"HPA039361: AB_10673527"					"unprognostic (1.83e-1)"						"unprognostic (2.62e-3)"	"unprognostic (1.22e-1)"		"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"		0.2	11.3	1.4	0.2	3.0	0.2	0.1	3.2	5.1	8.3	0.2	0.8	0.0	0.3	5.4	0.2	0.2	0.4	0.2	0.1	0.6	4.0	0.1	0.2	0.2	0.1	3.4	0.9	0.1	0.5	0.1	11.8	0.1	10.6	0.3	0.2	0.1	0.2	1.4	0.2	0.2	0.2	8.1	0.5	0.2	0.5	0.2	1.0	0.0	0.2	0.0	0.1	0.1	5.4	0.5	0.4	1.3	0.3	0.7	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.2	1.3	0.7	0.3	0.4	0.0	0.0	1.4	3.0	3.2	1.9	0.6	4.0	3.4	0.9	10.6	1.0
REM1	"GES, REM"	ENSG00000088320	"RRAD and GEM like GTPase 1"	O75628	20	31475293-31484905	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.7"	"Cell line enriched"	"Detected in single"	33	"WM-115: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 4.4"	HPA049821	Approved									"HPA049821: AB_2680898"	"unprognostic (6.16e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.39e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavourable (1.84e-6)"	"unprognostic (7.79e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-2)"	11.6	2.8	0.7	6.0	1.5	0.0	11.8	0.3	2.1	28.7	5.3	1.9	3.6	2.0	23.7	16.4	6.3	10.4	8.5	5.7	0.7	0.6	2.6	1.0	5.5	5.6	1.0	0.7	13.2	2.3	1.5	2.6	3.3	2.1	6.7	1.6	3.5	3.1	15.6	13.7	2.7	3.2	4.8	0.6	2.3	2.4	5.3	0.0	0.5	4.4	4.7	5.1	5.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.3	2.1	0.7	0.6	1.0	0.7	2.1	0.0
RGPD1	RGP1	ENSG00000187627	"RANBP2-like and GRIP domain containing 1"	P0DJD0	2	86907953-87013976	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.4;placenta: 8.0;testis: 17.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.0;MOLT-4: 13.5;NTERA-2: 4.1;RPMI-8226: 3.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA049497, HPA051675, HPA067564"	Uncertain		Approved	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"	"Nuclear membrane, Vesicles"	"HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (8.24e-2)"	"unprognostic (6.05e-2)"		"unprognostic (6.41e-2)"	"unprognostic (1.39e-2)"	"unprognostic (9.06e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.80e-1)"		"unprognostic (2.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.88e-5)"	"unprognostic (2.23e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.99e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	10.4	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.1	0.2		0.2	1.7	1.1	4.8	8.0		0.0	0.0		0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.3	0.3	17.7			0.2		0.5	0.0	0.1	1.3	0.0	0.1	0.0	1.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	13.5	0.2	4.1	0.0	0.1	0.1	3.0	0.0	0.0	0.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.7	0.0	0.2	0.1	0.8	0.0	1.1	0.0	0.0	0.1	0.1										
RORB	"NR1F2, ROR-BETA, RZRB"	ENSG00000198963	"RAR related orphan receptor B"	Q92753	9	74497365-74693177	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;cervix, uterine: 20.8"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.9;HSkMC: 10.9;MOLT-4: 5.6;SH-SY5Y: 11.7"	"Group enriched"	"Detected in some"	5	"glioma: 2.1;prostate cancer: 2.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008393	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA008393: AB_1079830"	"unprognostic (6.89e-3)"	"unprognostic (4.06e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.81e-8)"	"unprognostic (5.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.00e-2)"	3.1	7.9	8.3	1.2	11.1	1.0	1.4	1.8	35.5	20.8	1.3	2.1	2.2	1.1	8.9	0.9	1.7	1.5	4.5	3.9	5.6	7.0	2.0	1.0	2.0	0.9	4.1	18.7	1.4	1.1	1.1	4.0	10.6	6.1	10.5	1.6	18.7	1.2	11.7	0.9	1.3	1.1	1.7	6.7	1.0	1.6	2.0	3.7	2.2	1.5	0.0	1.5	2.3	2.2	0.2	0.2	1.8	0.2	0.6	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	19.9	0.0	0.6	10.9	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	5.6	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.2	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.4	2.7	0.0	1.3	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	1.8	0.6	0.1	0.2	0.0	0.0	8.3	11.1	1.8	35.5	5.6	7.0	4.1	18.7	6.1	3.7
RSPO1	"FLJ40906, RSPONDIN"	ENSG00000169218	"R-spondin 1"	Q2MKA7	1	37611350-37634923	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 17.3;endometrium 1: 26.6"	"Group enriched"	"Detected in some"	5	"HHSteC: 1.7;NTERA-2: 4.5;THP-1: 4.6"	"Cancer enriched"	"Detected in some"	13	"ovarian cancer: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA046154	Uncertain				"Secreted in female reproductive system"					"HPA046154: AB_10964912"	"unprognostic (1.50e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.99e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.75e-6)"		"unprognostic (1.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.13e-2)"		"unprognostic (1.93e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-2)"	5.0	0.1	0.2	1.9	0.3	0.0	5.8	0.5	0.6	17.3	2.1	0.2	0.2	0.6	26.6	3.0	1.8	15.8	12.2	0.4	0.2	0.0	0.7	0.2	4.5	1.9	0.2	0.2	7.5	1.6	0.0	0.2	1.3	0.4	3.0	0.2	2.3	1.5	1.4	0.2	4.0	3.1	10.9	0.2	0.7	2.0	1.0	0.2	0.2	0.2	1.3	6.1	1.3	8.8	0.4	0.3	0.7	0.5	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	4.6	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.7	0.2	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.7	0.0	0.5	0.3	0.3	0.0	0.2	0.3	0.5	0.6	0.2	0.0	0.2	0.2	0.4	0.2
SAA2-SAA4		ENSG00000255071	"SAA2-SAA4 readthrough"		11	18231423-18248635	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 15.9;cervix, uterine: 10.6;liver: 44.4"	"Cell line enhanced"	"Detected in some"		"A-431: 6.7;CAPAN-2: 1.5;EFO-21: 3.9;HaCaT: 2.7;RPTEC TERT1: 1.5;SiHa: 1.5"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 39.9"					"Cell type enriched"	"Detected in single"	10	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"									HPA060139	Uncertain									"HPA060139: AB_2684210"	"prognostic favourable (4.56e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.96e-1)"		"unprognostic (8.27e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (2.92e-8)"	"unprognostic (1.92e-1)"			"unprognostic (2.72e-1)"	15.9	0.6	0.0	0.7	0.0	0.0	2.7	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	44.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	1.5	0.0	3.9	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SCGB1D1	"LIPA, LPHA, MGC71958"	ENSG00000168515	"Secretoglobin family 1D member 1"	O95968	11	62190216-62193539	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 5.4;fallopian tube: 3.2;lymphoid tissue: 2.0"	"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 11.6"	"Group enriched"	"Detected in some"	40	"endometrial cancer: 23.3;ovarian cancer: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"									"unprognostic (6.95e-3)"						"unprognostic (9.01e-2)"								0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	5.4	0.1	0.1	0.1	0.0	1.1	0.1	1.4	3.2	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.1	2.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242210-62244808	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.5;cervix, uterine: 315.2"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.4"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035318	Approved				"Secreted in other tissues"					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favourable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favourable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		1.8	0.4	0.8	0.2	0.6	0.0	101.5	0.9	0.5	315.2	0.2	0.9	6.2	0.0	18.4	43.8	0.8	8.5	0.4	1.0	1.2	0.4	1.1	0.2	0.2	0.2	1.0	0.5	1.1	2.9	0.0	1.0	0.6	7.3	1.1	0.0	1.2	9.5	0.5	2.4	59.6	0.2	0.2	0.4	0.2	0.0	1.6	0.5	0.2	0.3	2.1	1.2	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.4	0.2	0.0	2.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.9	0.5	1.2	0.4	1.0	0.5	7.3	0.5
SERPINB12	YUKOPIN	ENSG00000166634	"Serpin family B member 12"	Q96P63	18	63556160-63567011	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 9.3;skin 1: 38.8;vagina: 16.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;CAPAN-2: 1.0;hTCEpi: 2.4;U-266/70: 2.9"	"Group enriched"	"Detected in some"	14	"cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									8500000	8500000					"unprognostic (7.35e-2)"				"prognostic favourable (1.76e-4)"		"unprognostic (1.57e-1)"	"unprognostic (2.00e-1)"						"unprognostic (8.10e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	9.3	0.0			0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.4	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.3			0.0		1.4	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 144.9;endometrium 1: 100.7;retina: 123.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 13.8;HSkMC: 5.4;U-937: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	1500000	1500000			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	4.6	2.3	0.5	0.9	0.9	0.0	12.5	0.3	0.4	144.9	0.8	1.7	5.4	0.0	100.7	11.5	3.2	35.1	2.5	5.5	0.4	0.4	1.2	0.2	3.9	0.8	0.8	0.7	42.7	1.4	0.1	4.0	0.4	1.3	4.9	0.2	123.0	2.3	7.1	1.4	0.3	0.5	14.5	3.3	4.1	0.5	5.8	0.3	0.4	3.3	2.5	0.5	8.8	14.8	0.4	0.8	0.4	0.6	0.1	0.1	0.0	0.0	2.5	2.8	0.0	13.8	0.6	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	2.9	0.1	0.0	0.3	0.3	0.0	0.0	0.2	0.2	2.0	0.1	0.4	0.0	5.4	0.7	0.6	0.0	0.2	0.0	0.3	0.2	0.4	0.0	1.6	0.1	0.0	0.2	1.7	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.9	0.0	1.2	1.6	0.2	0.5	0.1	0.2	0.3	5.2	0.9	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.5	0.9	0.3	0.4	0.4	0.4	0.8	0.7	1.3	0.3
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241263-11564063	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;cervix, uterine: 22.4"	"Cell line enriched"	"Detected in some"	7	"NTERA-2: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA023440	Uncertain									"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavourable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	2.2	0.7	5.8	0.6	5.5	0.2	1.2	9.8	7.5	22.4	0.9	2.5	1.9	0.4	4.2	2.4	0.9	1.7	0.5	1.1	12.1	9.9	2.5	0.2	1.5	0.2	11.8	2.9	0.6	1.4	6.0	0.0	0.3	13.6	5.9	0.8	0.8	0.2	10.1	1.0	0.5	0.4	1.2	9.6	0.2	6.0	2.9	2.1	0.0	0.7	0.0	0.2	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	9.8	4.9	12.1	9.9	11.8	2.9	13.6	2.1
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243667-44312851	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9"	"Cell line enhanced"	"Detected in some"		"SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	0.7	1.3	13.8	1.3	3.6	0.0	0.5	1.6	13.0	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.5	0.0	0.0	0.0	0.4	1.1	1.1	0.6	0.0	0.0	0.0	0.0	1.0	0.0	2.3	0.1	0.1	0.0	1.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	16.7	0.0	0.1	0.0	0.1	0.0	6.2	0.9	37.9	0.2	0.0	0.0	0.0	22.0	0.0	12.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5
SLC15A2	PEPT2	ENSG00000163406	"Solute carrier family 15 member 2"	Q16348	3	121894089-121944102	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.2;ductus deferens: 35.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.2;U-937: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.72e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (3.50e-2)"	"prognostic favourable (6.96e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.03e-3)"	"prognostic favourable (6.74e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.60e-2)"	1.0	1.2	13.8	1.9	15.0	3.3	3.2	4.0	15.3	35.2	1.8	7.6	35.8	1.5	1.5	26.2	3.6	7.4	4.2	2.0	14.6	5.3	7.4	1.1	12.9	3.6	5.3	12.9	1.0	3.6	2.4	3.6	1.6	6.8	26.5	2.1	15.1	14.6	25.1	0.8	0.7	2.2	0.9	4.0	6.1	1.1	3.9	6.7	0.0	4.6	0.5	3.8	3.6	2.6	4.2	1.6	2.4	2.5	0.3	0.3	0.3	1.8	0.9	1.1	0.4	1.3	0.7	1.4	0.2	0.1	0.5	0.6	1.7	3.2	3.4	0.2	0.1	2.0	0.8	1.8	0.6	2.7	0.6	4.9	1.3	0.8	0.2	5.1	4.9	1.0	5.4	0.5	0.4	0.3	0.7	1.5	0.6	1.4	1.0	8.2	5.6	0.5	1.2	0.5	1.0	1.2	1.2	0.4	0.4	0.5	0.3	0.1	0.3	4.6	0.1	0.4	0.3	0.4	0.4	1.8	0.5	4.9	0.5	7.0	0.5	2.4	1.1	0.4	0.3	0.4	0.3	3.3	0.3	0.2	0.3	4.2	0.3	0.3	0.6	0.3	2.5	1.6	0.2	0.3	13.8	15.0	4.0	11.0	14.6	5.3	5.3	12.9	6.8	6.7
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 89.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Supported	Vesicles,Centrosome				Vesicles	Vesicles	"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.2	89.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3
SMCO3	"C12orf69, LOC440087"	ENSG00000179256	"Single-pass membrane protein with coiled-coil domains 3"	A2RU48	12	14804650-14814182	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 13.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;HHSteC: 2.1;HUVEC TERT2: 1.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA040574, HPA047804"	Uncertain									"HPA040574: AB_2677026, HPA047804: AB_2680160"	"unprognostic (1.16e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.40e-4)"	"unprognostic (5.10e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.45e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-8)"	"unprognostic (2.85e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-1)"	1.3	0.8	0.2	0.2	0.2	0.3	0.6	0.2	0.4	13.3	0.6	0.2	0.2	0.0	1.3	0.7	0.8	0.8	3.7	2.3	0.2	0.1	6.6	2.8	4.3	0.9	0.6	0.7	1.2	0.6	3.1	0.7	4.0	1.4	2.1	0.1	5.1	0.2	3.2	2.2	0.3	0.4	0.2	2.5	3.3	0.4	0.6	0.2	0.2	8.5	0.9	0.2	1.1	1.6	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.1	0.5	6.2	0.7	0.0	0.6	0.8	0.0	0.0	0.0	0.2	0.7	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.3	2.1	0.0	0.1	1.4	0.0	0.0	0.5	1.8	0.3	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.5	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	1.5	0.4	0.0	0.5	0.7	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.2	0.2	0.4	0.2	0.1	0.6	0.7	1.4	0.2
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		430000	430000	Cytosol	Cytosol	"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favourable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.8	13.9	3.5	11.4	3.1	5.4	3.7	4.4	3.0	10.0	8.5	11.5	8.6	2.0	9.9	5.4	23.8	18.2	16.6	8.0	34.3	11.3	15.9	18.2	25.5	2.3	27.5	26.6	6.9	12.6	5.7	9.2	9.3	17.7	5.6	9.4	6.3	16.6	14.9	13.6	14.8	0.0	23.0	7.7	7.3	15.4	25.0	13.1	8.9	14.1	6.7	20.3	11.3	8.3	8.0	7.0	17.8	10.5	1.0	6.9	2.0	12.9	24.4	20.7	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 12.1;HeLa: 17.9;Karpas-707: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	28000000	28000000	Vesicles	Vesicles	"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	12.1	0.0	1.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.2	0.7	15.8	0.0	1.7	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.1	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Group enriched"	"Detected in some"	84	"HeLa: 239.2;SiHa: 114.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011039	Uncertain				"Secreted - unknown location"					"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favourable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	239.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1
STX18	Ufe1	ENSG00000168818	"Syntaxin 18"	Q9P2W9	4	4415742-4542346	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 98.6"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"endometrial cancer: 43.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003019	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA003019: AB_1857622"	"unprognostic (2.33e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.84e-4)"	"prognostic favourable (6.33e-8)"	"unprognostic (4.21e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"prognostic favourable (7.03e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	"prognostic favourable (4.69e-4)"	14.0	17.6	12.4	16.0	18.4	9.2	11.0	11.2	15.9	98.6	19.7	19.5	12.2	15.0	46.5	11.9	11.5	38.9	16.1	11.0	11.3	14.2	24.2	14.0	9.8	10.4	14.5	12.3	12.4	18.5	12.2	24.1	17.5	17.3	12.3	11.9	12.7	12.2	14.7	19.0	11.0	19.6	13.5	14.8	14.2	15.0	28.5	10.3	18.1	10.1	9.8	15.0	11.8	12.3	11.2	25.5	7.1	13.0	10.8	13.4	9.3	14.0	9.2	10.9	11.1	9.4	13.8	14.6	16.2	14.9	15.6	13.0	19.3	20.6	18.8	39.2	15.0	7.6	19.3	9.5	15.4	7.8	9.6	11.8	12.1	23.3	14.1	20.4	10.0	12.9	8.3	13.2	9.6	13.1	11.3	16.7	11.1	7.5	18.5	14.5	14.5	19.1	16.7	8.2	14.9	16.0	8.6	13.9	12.3	12.2	8.2	14.2	12.0	10.0	14.8	9.4	10.3	8.6	17.4	12.0	18.2	21.7	11.5	15.8	11.7	4.8	10.6	7.1	10.9	10.4	13.4	11.2	10.1	9.9	16.0	9.3	8.5	9.8	2.1	10.8	13.0	25.5	9.1	9.3	12.4	18.4	11.2	15.9	11.3	14.2	14.5	12.3	17.3	10.3
TAS2R9	"T2R9, TRB6"	ENSG00000121381	"Taste 2 receptor member 9"	Q9NYW1	12	10809094-10810168	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"cervix, uterine: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																															0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.2	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0										
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9"	"Cell line enriched"	"Detected in single"	10	"THP-1: 8.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044596			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA044596: "	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	28.0	0.5	0.0	0.5	0.0	56.4	7.2	0.1	14.0	0.4	0.6	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	49.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	16.7	0.1	6.2	0.1	7.5	0.0	0.0	0.1	0.0	0.0	0.7	1.5	1.8	1.4	4.4	1.0	1.3	1.2	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.1	0.6	0.3	0.1	0.8	0.1	0.7	0.0	0.3	0.2	0.1	0.2	0.3	0.0	0.3	8.6	0.0	0.2	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.0	4.4	1.0	0.9	1.0	0.5	0.8	1.1	1.1	0.8	0.2	1.8	1.2	1.0	3.9	1.3	0.5	1.4	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 60.5"	"Cell line enhanced"	"Detected in many"		"A549: 19.4;ASC TERT1: 18.2;BJ hTERT+: 23.0;T-47d: 18.8;TIME: 28.5;U-2197: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"						"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	2.4	4.6	1.5	3.6	2.7	0.2	8.5	1.4	3.0	60.5	8.7	2.4	5.1	4.3	19.9	12.8	36.9	20.3	18.7	17.4	2.1	2.0	5.1	3.3	5.0	2.3	2.7	4.2	8.0	8.7	1.2	4.5	12.4	5.3	19.0	4.0	29.7	6.5	8.8	1.6	4.4	8.4	10.6	6.4	1.2	6.2	3.9	1.4	0.0	6.6	13.3	5.3	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	19.4	0.3	5.6	3.0	18.2	0.0	9.4	23.0	4.9	2.5	0.1	3.7	0.0	7.8	3.3	7.3	0.7	3.9	3.0	0.8	0.8	0.0	2.0	0.0	1.9	0.0	0.0	1.3	2.9	2.9	11.8	8.9	0.0	0.2	4.0	3.8	0.0	0.0	1.7	3.4	0.0	0.3	0.3	13.0	2.6	0.3	2.4	3.8	4.7	0.0	18.8	0.0	28.5	0.1	0.4	19.4	5.0	0.0	0.1	0.0	4.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.7	1.4	3.0	2.1	2.0	2.7	4.2	5.3	1.4
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838230	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.0"	"Group enriched"	"Detected in some"	4	"BEWO: 3.3;HAP1: 10.3;NTERA-2: 4.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.2	0.0	0.9	0.0	0.7	0.0	0.2	0.2	1.1	3.0	0.0			0.0	0.2	1.3	0.7	0.7	0.2	0.0	0.7	0.5	1.4	0.0	0.0	0.0	1.0		0.2	0.0	0.0	0.0	1.1		0.7	0.0		0.0	0.3	0.2	0.0	0.0	0.0	1.5	0.0	0.0	1.1			0.0		0.3	1.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	10.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0										
TMEM260	"C14orf101, FLJ20392"	ENSG00000070269	"Transmembrane protein 260"	Q9NX78	14	56488354-56650606	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 61.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003502	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA003502: AB_1078314"	"unprognostic (4.63e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (7.11e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.81e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.84e-2)"	7.8	7.4	7.3	11.0	10.6	3.8	9.1	13.3	9.9	61.0	8.8	13.7	11.6	8.1	11.8	12.1	6.7	11.4	10.3	6.0	8.9	8.6	10.7	8.7	8.4	8.8	10.8	7.5	14.8	13.6	12.4	17.2	8.7	9.7	8.7	9.1	8.7	7.4	13.0	5.2	8.6	10.7	8.9	12.2	9.2	8.4	10.1	8.3	17.6	12.6	4.6	8.8	10.1	9.7	2.0	4.6	2.9	2.8	6.3	3.5	2.0	7.3	5.2	4.0	8.5	14.3	11.8	7.9	7.9	8.8	5.2	6.2	2.4	5.5	6.0	7.8	5.9	8.6	9.3	5.7	8.2	7.4	4.7	3.9	2.4	3.2	10.1	5.4	9.3	14.5	10.4	2.9	10.1	6.8	4.7	6.5	6.8	4.9	2.8	2.0	3.7	8.3	4.0	6.4	2.0	8.8	11.0	8.5	4.2	8.9	6.4	5.2	8.2	8.4	9.5	10.6	4.0	7.9	3.9	3.9	3.1	3.5	6.6	4.0	5.2	0.0	2.8	2.9	3.5	1.9	2.4	1.8	2.4	1.8	2.2	2.0	3.2	2.3	1.4	6.3	1.7	4.6	2.9	2.0	7.3	10.6	13.3	9.9	8.9	8.6	10.8	7.5	9.7	8.3
TMPRSS11A	ECRG1	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909385-67964140	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.5"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	47.6	18.7	0.3	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974305-129977938	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.1;T-47d: 2.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 13.3;endometrial cancer: 10.2"	"Group enriched"	"Detected in many"	14	"hypothalamus: 33.9;pons and medulla: 33.8"	"Group enriched"	"Detected in some"	11	"intermediate monocyte: 1.1;non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Group enriched"	"Detected in many"	5	"hypothalamus: 204.6;olfactory region: 182.2"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2.0	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1.0	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0.0	0.8	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	2.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	2.4	0.3	1.7	2.0	33.9	0.4	0.8	33.8	0.0
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910543	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 34.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.8;ASC TERT1: 20.9;BJ: 26.6;BJ hTERT+: 83.9;fHDF/TERT166: 38.0;U-2197: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 11.2"	"Lineage enriched"	"Detected in single"	52	"granulocytes: 11.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062870			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA062870: AB_2684888"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	25.8	1.3	0.2	4.7	0.6	0.6	21.7	0.1	0.4	34.6	8.4	0.4	4.3	0.6	14.3	6.2	9.1	7.4	5.8	4.3	0.6	0.2	0.7	0.3	4.2	0.9	1.1	0.0	15.6	0.7	0.0	2.1	9.1	0.4	13.1	1.9	3.9	2.2	7.1	4.3	9.7	2.3	12.4	1.7	1.2	3.3	4.6	0.5	0.0	4.0	6.4	3.4	15.9	18.6	0.2	0.0	11.2	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	32.8	20.9	0.0	26.6	83.9	12.4	18.7	0.0	0.0	0.0	0.8	38.0	0.2	0.3	2.1	9.1	0.0	2.8	0.0	1.6	0.1	5.6	0.0	0.6	4.8	1.1	6.0	5.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	4.6	0.5	0.9	32.5	0.3	0.0	0.0	0.0	0.1	0.8	1.7	0.0	0.1	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.3	0.6	0.2	1.1	0.0	0.4	0.5
VSIG10L2		ENSG00000283703	"V-set and immunoglobulin domain containing 10 like 2"	P0DP72	11	125946056-125958647	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.6;skin 1: 20.4"	"Cell line enhanced"	"Detected in some"		"AF22: 1.2;AN3-CA: 1.1;SH-SY5Y: 2.7;SK-BR-3: 1.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	2.3	0.0	0.9	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.8	0.0	0.0	20.4	0.2	0.6	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WISP2	"CCN5, CT58, CTGF-L"	ENSG00000064205	"WNT1 inducible signaling pathway protein 2"	O76076	20	44714844-44728509	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 109.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.8;ASC TERT1: 26.3;HeLa: 14.7;HSkMC: 10.6;U-2197: 83.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB019273	Approved				"Secreted to extracellular matrix"	400000	400000			"CAB019273: "	"unprognostic (1.87e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.76e-10)"	"unprognostic (1.55e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.28e-1)"	57.0	6.5	0.2	2.0	2.2	0.4	32.7	0.1	0.5	109.7	4.7	0.6	8.6	0.6	7.0	12.4	47.1	5.5	8.4	29.7	0.3	0.0	0.5	0.9	25.6	0.9	0.1	1.4	48.4	1.8	0.7	0.0	0.9	0.2	20.1	0.9	0.5	4.3	8.9	18.0	30.6	1.4	22.0	0.2	0.5	1.4	37.7	0.4	0.0	2.5	3.7	0.6	18.2	18.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	9.8	26.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.1	0.5	0.3	0.0	0.1	1.4	0.2	0.4
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.1;HEK 293: 9.8;hTEC/SVTERT24-B: 2.9;U-2197: 4.7;U-266/70: 2.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	125	"memory B-cell: 13.1;naive B-cell: 11.8"	"Lineage enriched"	"Detected in single"	132	"B-cells: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.3	0.5	0.8	0.7	1.0	0.2	2.0	0.9	2.2	19.7	1.0	0.2	11.7	0.2	2.1	7.9	0.3	0.4	0.3	0.2	0.8	0.4	0.2	0.4	0.4	1.3	0.8	0.9	0.1	0.2	0.1	0.6	0.8	1.6	1.0	0.3	0.0	0.5	4.0	0.3	24.4	0.7	0.3	2.3	1.2	0.3	0.6	0.8	0.0	0.2	0.0	0.6	0.5	5.5	13.1	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.3	4.1	0.3	0.0	0.9	1.0	0.0	0.0	0.1	0.0	9.8	0.0	0.4	0.1	0.0	0.0	0.0	1.9	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.5	2.9	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.0	0.9	2.2	0.8	0.4	0.8	0.9	1.6	0.8
XG	PBDX	ENSG00000124343	"Xg blood group"	P55808	X	2752048-2816500	"Blood group antigen proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8"	"Group enriched"	"Detected in some"	6	"ASC diff: 33.7;ASC TERT1: 25.0;fHDF/TERT166: 15.7;hTCEpi: 23.4;T-47d: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 2.1;naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.1"					"Low region specificity"	"Detected in all"														"prognostic unfavourable (4.25e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-6)"	"unprognostic (3.96e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.77e-3)"	8.9	0.0	0.3	0.3	0.6	0.8	9.1	0.5	0.6	22.8	0.3	0.3	0.3	0.0	2.6	0.3	7.1	0.6	3.0	1.2	1.4	0.0	1.3	0.3	0.3	0.3	0.6	0.3	1.1	0.3	0.0	0.3	18.4	1.9	0.5	0.0	0.3	4.1	0.4	1.4	25.8	0.3	0.3	4.2	0.3	0.1	0.3	0.3	0.3	0.9	0.3	2.4	1.2	7.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	25.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	23.4	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	1.7	12.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	1.4	0.0	0.6	0.3	1.9	0.3
